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ABSTRACT 
 
The Recovery of Protein from Egg Yolk Protein Extraction Granule Byproduct 
Irene J. Kaufman 
 
In addition to proving an excellent source of nutrients, eggs are used in the food, 
cosmetic, and biotechnology industries for their rheological and bioactive properties. 
Much of the potential for the added value is in individual components of the egg, rather 
than the whole egg. At low speed centrifugation, yolk separates into two distinct 
fractions—granules and plasma. It is becoming increasingly popular in the industry to 
remove the plasma fraction of the egg yolk to use for its livetins, particularly 
immunoglobulin Y, leaving behind a granule by-product (“yellow cake”). Previous 
research has shown potential added-value from the granule fraction, especially from its 
phosvitin and phospholipids. Granules are protein aggregates with complexes of 
phosvitin and high density lipoproteins linked by phosphocalcic bridges. In their native 
form, the proteins are mostly insoluble, however previous studies have shown the links 
can be broken by alterations in pH, ionic strength, and mechanical treatments. This thesis 
project seeks to find potential uses for the egg yolk by product after the removal of the 
livetin fraction by means of further fractionation with mechanical treatment (filtration). 
Two variables were tested to extract more proteins from the yellow cake. Salt was added 
to 10% solids solution of yellow cake in water before filtration at four different NaCl 
levels: 0%, .05%, 1%, and 2.5%. Additionally pH was tested at four different levels: 4.6, 
4.8, 5.0, 5.2. The samples were also tested for antibacterial properties against Escherichia 
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coli with a minimum inhibitory concentration assay (MIC). Analysis with BCA showed 
salt concentration had a significant effect on the yield of protein. The highest 
concentration of salt tested, 2.5%, had the highest protein yield. Additionally, SDS-
PAGE showed 2.5% salt had the most unique protein bands. This could be to the 
disruption of the phosphocalcic links between the phosvitin and HDL by NaCl, allowing 
the protein to solubilize. pH did not have a significant effect on the yield or types of 
proteins in the range tested in this experiment. There is no conclusive evidence of 
antibacterial properties against E. coli from the protein extract. The MIC assay had 
growth show up in all wells with the protein extract, however there was a visible decrease 
in turbidity with higher concentration of the protein extract. This could mean that the 
protein extract does have some antibacterial properties, but needs testing at higher 
concentrations or with isolated proteins/peptides. The SDS-PAGE revealed bands 
showing phosvitin present, which has known antibacterial properties. Overall, 
improvements to the methods for further protein extraction from egg yolk by-products 
will help lead the industry to finding novel uses and product applications.    
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CHAPTER 1: INTRODUCTION 
Hen eggs have long been acknowledged as a good source of nutrition in the food 
industry. They provide an excellent source of essential protein, fat, vitamins and 
minerals. Eggs have also been touted for their use as an emulsifier in foods, as well as 
cosmetics. In more recent years, eggs are being recognized for their benefits beyond basic 
nutrition and emulsification. Eggs, and their components, are found to contain health 
benefits and bioactive properties (Anton et al., 2006). Some of these beneficial properties 
are found in individual components of the egg, rather than the whole egg.  
 
While egg yolks are generally sold as whole, there is more potential added value in the 
applications of its fractions. At low speed centrifugation, yolk separates into two distinct 
fractions—granules and plasma. The plasma is comprised of low-density lipoproteins and 
livetin. Granules are composed of high-density lipoproteins, phosvitin, and low-density 
lipoproteins (Anton and Gandemer, 1997). It is becoming increasingly popular to remove 
livetin from the water-soluble fraction (plasma) of the egg yolk.  The three types of 
livetin include α-livetin, β-livetin, and γ-livetin (Mine, 2008). Of these, γ-livetin, referred 
to as IgY, is of particular interest because of its potential immunotherapeutic and 
immunodiagnostic properties. IgY from egg is analogous to the mammalian 
immunoglobulin IgG, but has many benefits, including cost, and a reduction and 
refinement in animal use (Karlsson et al., 2004). As the use for egg yolk fractions 
expands, including commercial scale IgY extractions, there has been an increase in 
leftover yolk product after removal of livetin. Use of granules has not been as extensively 
studied, but has added- value potential, especially in its phospholipids and phosvitin. 
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Granules are tightly compact in their structure, with complexes of phosvitin and HDL 
linked by phosphocalic bridges. Untreated, the proteins are largely insoluble, but can be 
broken by alterations in pH, ionic strength, and mechanical treatments.  
 
The purpose of this thesis is to look to recover and characterize the proteins leftover in 
the by-product of a large IgY extraction representative of many of the current models of 
extraction. Specifically, this thesis seeks to understand the effect of mechanical 
treatments, pH, and NaCl concentration on protein recovery. Furthermore, it explores the 
potential anti-microbial activity of the recovered proteins.   
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CHAPTER 2: LITERATURE REVIEW 
2.1 Egg Yolk Introduction 
2.1.1 History  
Hens’ eggs are important in the embryonic stage of development of the chick, serving 
as a source of energy and protection. The unique egg components designed for 
development are also what make them a good source of nutrition, functional activity, 
and biotechnological agents (Anton, 2006).  Eggs have been consumed by humans for 
as long as we have existed. Birds and eggs predate humans, and evidence has found 
that wild fowl were domesticated since 3200 B.C. Descendants of chickens used for 
egg laying today are believed to have been brought to America with Columbus’ ships 
in 1493.  In the mid-late 1900’s major improvements to sanitation and technology 
were made, shifting small family flocks to large commercial egg operations. 
Continued improvement in caging, automation, and hen health has since led to higher 
production, better hen health, uniform quality, and lower costs. (AEB, 2017). Since 
the 1960s, advances include efficient egg breaking machines, better technology in 
pasteurization, improved freezing methods, and better spray driers (Mine, 2008). The 
average laying hen produced 160 eggs in 1960, and from all the improvements has 
increased to an average of 325 eggs in 2009 (Purdue Agriculture: Food Animal 
Education Network, 2008). 
 
With improved technology in processing eggs, there has been an increase in further 
processed egg products. Examples of egg products are hard boiled pre chopped eggs, 
omelets, quiches, precooked scrambled eggs, precooked egg patties, and scrambled 
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egg mixes. Some processed egg products are used in the form of ingredients, 
including liquid whole egg yolk, whites, frozen yolk, and dried yolk or whites (Mine, 
2008). Egg components are also being used in the cosmetic, medical, and 
nutraceutical industries (Anton, 2006).  
 
The yolk of the chicken egg serves the biological function of sustaining the 
developing chicken embryo with lipids, proteins, vitamins and minerals, as well as 
preparing the first immune defense for the embryo. The aggregate of antibodies from 
the mother provide the embryo with this immunity (Mann, 2008). As well as its 
reproductive purposes, the yolk has uses in industry, including food, cosmetics, and 
biotechnology. The yolk provides a rich source of dietary lipids, proteins, vitamins 
and minerals (Anton, 2006) Yolk’s unique properties make it a good food emulsifier, 
often used in the case of mayonnaises, salad dressings, and cream (Anton, 2013).  
 
2.1.2 Nutritive Value 
Eggs are known worldwide as an exceptional source of nutrition, especially providing 
a low cost, high quality source of protein. Whole egg protein holds the highest 
biological value, 94, of any of the major food protein sources (Mine, 2008). Though 
protein is found throughout the entire egg, most of it is found in the egg white (50%) 
and egg yolk (40%) with the remaining found in the shell and shell membranes. 
(Abdou, 2013).  Eggs contain all nine essential amino acids that humans require in 
our diets.  Additionally, eggs are a good source of lipids, vitamins and minerals. The 
yolk contains vitamins A, D, E and K, as well as a good source of iron and 
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phosphorous. B1 and B12 are deposited in the albumen. The yolk and albumen both 
equally contain B2 and B9 (Anton, 2006).  Song and Kerver (2000) found that the 
daily nutrient intake of people that consumed eggs was significantly higher than that 
of those who do not consume eggs. The study included fat (saturated and 
polyunsaturated), cholesterol, fiber, sodium, Vitamins E, A, C, B6, B12, and folate. 
They found all of these nutrients except fiber and B6 were higher in the egg 
consumers. Additionally, there was no association with high serum cholesterol 
concentrations (Song et al., 2016).  Further, the food industry can fortify eggs with 
beneficial nutrients through the diet of the hen. Omega-3 fatty acids, lutein, and 
Vitamin E are commonly added to eggs to enhance nutrition (Mine, 2008). 
 
2.1.3 Beyond Nutrition 
Health benefits of food today are not solely assessed on their macronutrient and 
micronutrient content. Scientific research is finding that certain foods have 
physiologically active components that add value besides the established nutrients 
they contain; these foods are called functional foods. The International Food 
Information Council (IFIC) explains functional foods as “foods that provide health 
benefits beyond basic nutrition.” These foods include whole foods, as well as 
fortified, enriched, or enhanced foods, and can possibly lead to the reduction of 
disease (ADA, 2004).  
 
Eggs yolks are mostly made up of lipids (65%) and consist of triglycerides, 
phospholipids (PL), cholesterol, and free fatty acids. The omega 3 fatty acids and 
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phosphatidylcholine (PC) found in the yolk are of special interest due to their 
importance of in brain development and function, particularly for infants. PC and 
other phospholipids are being studied as a potential treatment for neurological 
disorders (Kullenberg, 2012).  Egg yolk phospholipids have three times more PC than 
from natural soy phospholipids (Anton, 2006).  Research in dietary PC has showed 
some evidence of cancer prevention. Suppression of nodule formation related to 
hepatic cancer and preneoplastic liver lesions were found in a study with PC 
supplementation in rats. It has also been found that the PLs could reduce the negative 
gastrointestinal side effects of non-steroidal anti inflammatory drugs when paired 
together (Kullenberg, 2012). 
 
2.2 Structure and Composition 
2.2.1 Whole Egg Structure 
The main components of a hen’s egg are the ovum (yolk), albumen (white), shell 
membranes, and shell. The shell consists of three layers; the outermost layer is the 
cuticle, then a calcium carbonate layer, and an innermost mammillary layer.  
 
 
Figure 2.1 Structure of whole egg (Mine, 2008) 
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2.2.1.1 Shell and Shell Membrane 
The shell makes up ~11% of the egg (USDA, 2000). Eggshells’ main purpose is to 
protect the egg against physical damage and microorganisms. (Mine, 2003) The shell 
membrane is just below the inner surface of the shell and encompasses the albumen. 
It consists of two membranes, inner and outer, that together are only 0.00609 mm 
thick. The inner membrane is made up of 3 layers of fibers that run parallel to the 
shell, while the outer membrane consists of 6 layers in different directions. The main 
purpose of the shell membrane is to contribute to the strength of the shell (Mine, 
2008).  
 
2.2.1.2 Albumen and Ovum 
The albumen, often referred to as the egg white, is made up of four layers. Total it 
represents ~58% of the egg. (USDA, 2000) Its main function is to deliver nutrients to 
the chick embryo during development. The albumen also serves to protect the yolk 
from harmful microorganisms (Abdou et al., 2013). There are two outer layers, one 
thick and one thin, and two inner layers. The outer thin layer next to the membrane is 
~23.3%, followed by the outer thick white layer at ~57.3%. The thick layer is more 
viscous because of its high concentration of ovomucin. The inner thin layer that 
makes up ~16.8% of the white, and innermost to the yolk is the calaziferous layer, 
~2.7% (Mine, 2008).  The chalaziferous layer, attached to the chalazae, encompasses 
the egg yolk. Although thin, it is a gelantinous strong layer that holds the yolk in 
place (USDA, 2000). 
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The ovum, most often referred to as the yolk, consists of about 31% of the total 
weight an egg (USDA, 2000). It is composed of a three layer membrane called the 
vitelline membrane surrounding the yolk. Most of the yolk is made of yellow yolk, 
with only 2% white yolk (Mine, 2008). The more complex microstructure of the yolk 
will be covered in more detail. 
 
2.2.2 Whole Egg Composition 
The majority of the egg by weight is water, totaling 75%.  Proteins and lipids 
constitute the majority of the rest of the egg, along with small amounts of 
carbohydrates and minerals (Mine, 2008). While these are the main contribution to 
human nutrition, there are also other minute components that are being studied for 
their biological activities and functional properties.  
 
 
 
 
 
Table 2.1 Composition of Egg (adapted from USDA, 2000) 
 Percent Water Protein Fat Ash 
Whole 
egg 
100 65.5 11.8 11.0 11.7 
White 58 88.0 11.0 0.2 0.8 
Yolk 31 48.0 17.5 32.5 2.0 
  Calcium 
carbonate 
Magnesium 
carbonate 
Calcium 
carbonate 
Organic 
matter 
Shell 11 94.0 1.0 1.0 4.0 
 
 
 
By weight the shell is ~94% calcite, with the remaining components mostly 
glycoprotein, proteoglycans, and minerals (Mine, 2003). The shell membranes are 
composed largely of 90% protein, with small amounts of ash and glucose. Water 
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makes up most of the albumen, with proteins making up the highest amount of solids, 
about 10% of the total weight of the white. Glucose, lipids, and minerals are also 
present in smaller amounts (Mine, 2008).  There are ~40 different proteins in the 
albumen, the majority composed of ovalbumin. About half of the total protein found 
in eggs is found in the albumen, 40% in the yolk, with the remainder in the shell and 
shell matrix (Abdou, 2013). The yolk is 50% solids. Lipids make up ~70% of the yolk 
(solid matter) and proteins ~30% (Mine, 2008).  Ovovitellin makes up the majority of 
the yolk protein. Of the lipid content, triglycerides make up 65.5%, phospholipids 
28.3%, and cholesterol 5.2%. The pH of the yolk when freshly laid is ~6.0, and after 
storage rises to ~7.0 (USDA, 2000). The yolk is composed of plasma and granule 
fractions, which will be covered in more detail in following sections. 
 
Table 2.2 Major Albumen Proteins (Adapted from Awade, 1996) 
Protein Amount of total protein (%) 
Ovalbumin 54 
Ovotransferrin 12-13 
Ovomuvoid 11 
Lysozyme 3.4-3.5 
Ovomucin 1.5-3.5 
G2 ovoglobulin 1.0 
G3 ovoglobulin 1.0 
Ovoflavoprotein 
Ovostatin 
Cystatin 
Avidin 
0.8 
0.5 
0.05 
0.05 
          
 
 
 
 
 
 
 
 
 
10 
 
Table 2.3 Major Yolk Constituents (Adapted from Mine, 2008) 
Constituent Major Component Relative % 
Proteins Apovitellenin I-VI 37.3 
 Lipovitellin apoproteins  
    α-Lipovitellin 26.7 
    β-Lipovitellin 13.3 
 Livetins  
    α-Livetin  2.7 
    β-Livetin 4.0 
    γ-Livetin 2.7 
 Phosvitin 13.3 
 Biotin binding protein Trace 
Lipids Triglyceride 65 
 Phosphatidylcholine 26 
 Phosphatidylethanolamine 3.8 
 Lysophosphatidylcholine 0.6 
 Cholesterol 4 
 Sphingomyelin 0.6 
 
 
2.2.3 Yolk Composition 
Composition of egg yolk can vary depending on the diet of the hen.  Yolk mainly 
consists of proteins and lipids. Supplementation of various minerals or foods high in 
omega-3 fatty acids have been reported as changing the protein and lipid content, and 
have been used in industry to fortify the yolk for enhanced nutrition (Mine, 2008).  
The yellow pigment of the yolk, xanthophyll, comes from greens and corn in the 
hen’s diet (USDA, 2000).  Light centrifugation will separate the yolk into a plasma 
supernatant that makes about 77-81% of the yolk dry matter and a granule precipitate 
that makes up 19-23% (Anton, 2013).  Plasma is composed of 85% low-density 
lipoproteins (LDL) and 15% livetins. Granules are composed of 70% high-density 
lipoproteins (HDL), 16% phosvitin, and and 12% LDL. (Anton, et al., 2000) As 
previously mentioned, numerous vitamins and minerals are present in the egg yolk. 
There is also a small amount of carbohydrate present in yolk, about 0.7-1.0%, mostly 
11 
 
bound as glycoproteins and glycolipids (Mine, 2008). Figure 2.2 breaks down the 
plasma and yolk components and their relative proportions.  
 
 
 
Figure 2.2 Composition of Yolk (Anton, 2013)  
 
 
2.2.3.1 Lipids 
Yolk lipid is made up of ~65% triglycerides, 28-30% phospholipid (PL), and 4-5% 
cholesterol. Composition of lipids can be affected by the hen’s age, genotype, and 
diet (Mine, 2008).  Research has suggested there are human health benefits to eggs 
fortified with PUFAS by means of the hen’s diet. The essential fatty acid ratio in 
untreated egg yolk is about 9:1 n-6 PUFA to n-3 PUFA, while the healthy 
recommended proportion associated with reduced risk of cardiovascular disease is 5:1 
(Marcet et al., 2014). A study by Milinsk et al. fed hens diets with different oils 
containing different amounts of fatty acids. They determined that the addition of oils 
into the diets were able to produce eggs with higher n-3 to n-6 ratio in the yolk lipids, 
while not affecting cholesterol content (2003).  
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The lipids in yolk are a majority triacylglycerols, or triacylglycerides (TG). Saturated 
palmitic acids and stearic acids make up ~30-38%  of the fatty acids in yolk lipids, 
and monounsaturated  and polyunsaturated fatty acids make up another ~30% (Mine, 
2008). A study by Brady et al., 2002 suggests that the TG released from the inner 
core of the lipoprotein is likely responsible for the antibacterial effect of egg yolk 
lipoprotein (Brady, 2002) Phosphatidylcholine (PC) and phosphatidylethanolamine 
(PE) are the major egg yolk PLs. Respectively, they make up ~81% and 12% of egg 
yolk lecithin. Lysophosphatidylcholine (LPC), lysophosphatidylethanolamine (LPE), 
and sphingomyelins are also present in smaller amounts in yolk PL (Mine, 2008). 
 
Sphingomyelins are only a minor constituent of yolk phospholipids. Although they 
only make up ~2% of yolk lipids, they are important. Sphingomyelin may have 
chemoprotective properties, as well as therapeutic preventative uses (Barrenetxe et 
al., 2006). It also plays an important role in the cell membranes of mammalian 
tissues, particularly in the brain and nervous tissues, working to regulate cholesterol 
(Slotte et al., 2007). Cholesterol makes up ~1.6% of total egg yolk, and ~5% of the 
egg yolk lipids (Mine, 2008). 
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Table 2.4 Composition of yolk, granules and plasma (g/100g dried matter) 
(Adapted from Anton and Gandemer, 1997) 
 
Constituent Yolk Granules Plasma 
Proteins 33.2 63.8 24.6 
Lipids 63.4 30.7 72.6 
Triglycerides (TG) 43.2 19.6 51.7 
Phospholipids (PL) 17.7 11.1 18.2 
Phosphatidylcholine (PC) 15.7 10.0 16.0 
Phosphatidylethanolamine 
(PE) 
2.0 1.1 2.1 
Cholesterol 2.6 1.3 2.7 
Lipids/Proteins 1.9 0.5 3.0 
PL/TG 0.41 0.61 0.35 
PC/PE 7.5 9.1 7.6 
 
 
2.2.3.2 Proteins 
LDL accounts for about two thirds of the yolk’s total protein.  It has a low density of 
.98 because its high lipid to protein content. It is responsible for much of the 
emulsifying functionality of egg yolk. LDL has at least two subfractions, called 
differing names such as LDL1 and LDL2, LDF1 and LDF2, and LDP1 and LDP2 
(Mine, 2008). A study by Jolviet et al. (2006) showed there were nine major protein 
bands by SDS-PAGE. Two bands were a monomer and dimer of apovitellin I, and all 
other bands were associated with fragments of apolipoprotein B (2006).  
 
HDL has a higher protein content of 80%, to a lipid content of 20% (Mine, 2008). 
The high protein content of HDL accounts for granules’ density of 1.190 g/mL. 
(Strixner and Kulozik, 2013). HDL is composed of α- and β-lipovitellins, which vary 
in amino acid composition (Mine, 2008). HDL makes up about a sixth of the yolk 
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solids in the granular fraction. It exists as a complex with phosvitin (Abdou et al., 
2013).  
 
Phosvitin is a phosphoglycoprotein with a high phosphorous content of ~10%. It is 
one of the most phosphorylated proteins in nature. Although it is insoluble in water in 
untreated conditions, with low ionic or acidic conditions, it can become soluble and 
has an ability to form a complex with metal ions (Abdou et al., 2013) Phosvitin is 
responsible for 60% of total egg yolk phosphoproteins and ~90% of the phosphorous 
in yolk (Samaraweera et al., 2011).  
 
Livetin makes up 30% of the plasma proteins. It is made of α-livetin, β-livetin, and γ-
livetins, which are analogous to the mammalian plasma proteins serum albumin, α2 
glycoprotein, and γ-globulin, respectively (Mine, 2008). Most research has been done 
on the immunoglobulin IgY because of its promising uses. The γ-livetins, referred to 
as IgY, are the major antibodies found in hen’s eggs. The IgY comes from the hen 
serum IgG, but has a different name to distinguish it from mammalian IgG (Mine, 
2008). There are about 100-400 mg IgY in an egg, with 1.23 times more in the yolk 
than in the serum concentration (Abdou et al., 2013).  
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Table 2.5 Properties of Yolk Proteins (Adapted from Mine, 2008)  
Protein Percent Localization Molecular Weight Characteristics  
Low-density  
  lipoprotein 
  (LDL) 
65 Plasma and  
granules 
10,300 kDa 
(LDL1) 
3,300 kDa 
(LDL2) 
Lipid content ~90% 
Apovitellenins I-VI known  
as lipoproteins 
Lipovitellin; 
  high-density 
  lipoprotein 
  (HDL) 
16 Granules 400 kDa 
   (α, β- 
   lipovitellin 
   complex) 
Lipid content ~25% 
    
Livetin 10 Plasma 80 kDa α-livetin 
40, 42 kDa  
   β-livetin 
180 kDa γ-livetin 
Serum albumin 
Fragment ofC-terminus 
   in vitellogenin 
IgY (hen’s serum IgG) 
Phosvitin 4 Granules 33, 45 kDa Most phosphorylated  
   protein in nature 
Egg yolk 
   riboflavin- 
   binding 
   protein (RBP) 
 
0.4 Plasma 36 kDa Similar to flavoprotein in  
   egg white and to serum  
   RBP 
 
Others 4.6 Mainly plasma   
 
 
2.2.4 Yolk Microstructure 
Egg Yolk is composed of non-soluble protein aggregates dispersed in a clear solution 
of soluble proteins and low-density lipoproteins. The non-soluble aggregates are 
called granules, and the soluble solution is called plasma. Centrifugation can easily 
separate the yolk into these two fractions (Anton, 2013). Plasma and granules exhibit 
different functionality, due to their differing compositions and structures.  
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Figure 2.3 Egg Yolk Structures (Anton, 2013) 
 
2.2.4.1 Plasma 
Plasma consists mainly of LDL and livetins, and is known to be soluble in its native 
form. Plasma is known as a useful emulsifying agent. The emulsifying properties of 
plasma behave similarly to yolk, while granules behave differently. This suggests that 
the plasma fraction is responsible for the yolk’s emulsifying capability.  Specifically, 
the LDL has been attributed with the excellent emulsifying properties (Jolviet et al., 
2006).   
 
 
 
  Figure 2.4 LDL Structure (Anton, 2013)  
 
LDL are spherical nanoparticles that range from 17nm to 60 nm in diameter. They 
have a lipid core made of triglycerides and cholesterol esters surrounded by a 
monofilm of phospholipids and proteins.  LDL proteins are non-soluble in water or 
aqueous buffer, making direct adsorption difficult, shown in Figure 2.5. The 
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nanostructure of the LDL is what allows the transport through the aqueous phase in a 
soluble form to the interface to then be released (Anton, 2013). Jolviet et al. (2006) 
identified two apoproteins from purified LDL—Apovitellenin I and Hen 
Apolipoprotein B (2006). Their study suggests that it is the apoproteins that serve as 
the initial anchorage at the interface, then initiate disruption of the structure and 
denaturation of the protein, leading to the spread of LDL at the interface.  
 
 
 
Figure 2.5 LDL Adsorption (Anton, 2013) 
 
Livetin is a water-soluble, non-lipid, globular glycoprotein. Immunologically it is 
analogous to mammalian protein plasma (Abdou et al., 2013). The structure of IgY 
and mammalian IgG are similar; both have two heavy chains and two light chains, but 
also come with differences. The molecular mass of IgG is 150 kDa, and 180 kDa for 
IgY. It has been proposed that IgY is more hydrophobic than IgG, favorable to the 
high lipid environment in egg yolk. The different amino acid sequences and structure 
cause different functionality in the immunoglobulins (Karlsson et al., 2004).  
Research has shown that IgY is accompanied by a polypeptide complex called yolkin. 
Yolkin is an immunostimulatory heterogeneous set of proteins that range in size from 
1-35 kDa (Zablocka et al., 2014).  
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2.2.4.2 Granules 
Granules are made up of protein aggregates ranging from 0.3μm to 2μm in diameter. 
Granules are mainly insoluble in their native form, as the HDL and phosvitin form 
complexes linked by phosphocalcic bridges (Anton, 2013). The HDL and phosvitin 
both have high amounts of phosphoserin amino acids that are able to bind calcium. 
These phosphocalcic bridges make the structure of the granule compact, poorly 
hydrated, and weakly accessible to enzymes. This leads to an efficient protection 
against thermal denaturation and heat gelation. The heat stability attributes of the 
granule fraction makes them a better choice for emulsion stabilization over plasma or 
yolk (Sirvente et al., 2007).  Phosphopeptides have a molecular structure that allow 
that usually contain clusters of phosphoserines, which is responsible for binding 
calcium and inhibiting the formation of insoluble calcium phosphates. The phosvitin 
in egg yolk is of particular interest because a molecule of it has ~120 phosphoserine 
residues, as opposed to a casein subunit with only 1-13 residues. This could produce 
calcium binding and releasing capabilities (Samaraweera et al., 2011).  
 
2.3 Bioactive Proteins  
Many foods contain proteins that have reported biological activities. Such activities 
include antimicrobial, anti hypertensive, anti oxidative, vitamin and mineral binding, 
immunoregulatory and immunosuppressing, and enzyme inhibitory properties. Often 
it is the peptides released during food fermentation or from enzymatic proteolysis 
during digestion that possess the biological activities (Walther and Sieber, 2011). 
Eggs are a valuable source of such proteins and peptides with biological properties. 
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These active molecules potentially provide use in the medical, pharmaceutical, 
cosmetic, nutraceutical and biotechnological industries (Anton et al., 2006).  The use 
of peptides and proteins with antimicrobial activity is of particular significance to 
medicine, pharmacology, and the food industry because of recent microbial resistance 
to antibiotics. Such proteins and peptides are able to inhibit or attack pathogenic 
microorganisms, but leave the host cells unharmed.  Greater insight on antimicrobial 
peptides could help a better understanding of the resistance mechanisms in bacteria 
and a potential replacement of antibiotics as a therapeutic agent against pathogenic 
diseases (Coutinho et al., 2007).  
 
While egg white bioactive proteins and peptides have been more extensively 
researched and used in the food industry, yolk proteins are currently less described. 
Though many components of the egg white contain biological activity, this section 
will briefly describe a few of the most abundant and used bioactive protein 
applications in the egg white, but this thesis will focus on the utilization of the 
bioactive proteins and peptides in the yolk portion.  
 
2.3.1 Egg White Bioactive Proteins 
2.3.1.1 Lysozyme 
Lysozyme is a widely used enzyme across the world in the foods and 
pharmacological industries. It is used to preserve fresh produce and meats by coating 
the surfaces, added to cheeses to control undesirable bacteria, and added to some 
wines to replace SO2 to inhibit malolactic fermentation. More than 100 tons of 
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lysozyme are used annually (Mine et al., 2004). The antimicrobial activity of 
lysozyme is effective against Gram-positive bacteria. It breaks down peptidoglycan, 
the structural component of Gram-positive bacterial cell walls, by splitting its β-(1,4) 
linkages between N-acetylmuramic acid and N-acetylglucosamine (Xu et al., 2007). 
Although lysozyme is commonly found in nature, including humans’ secretions and 
tissues, hens eggs are a richer and easily available source of the enzyme (Abdou et al., 
2013).  
 
Table 2.6 Properties of Egg White Proteins (Adapted from Mine, 2008) 
Protein Proportion of 
Albumen (%) 
Molecular  
Weight (kDa) 
Characteristics 
Ovalbumin 54 45 Enzyme inhibitor; 
binds Fe, Mn, Cu 
Ovotransferrin 12 76 Binds metallic ions 
Ovomucoid 11 28 Inhibits trypsin 
Ovomucin 3.5 110 Inhibits viral  
   Hemagglutination                    
Lysozyme 3.4 14.3 Lyses some bacteria 
Ovoglobulin G2 1 33-49 Good foaming agent 
Ovoglobulin G3 1 33-49 Good foaming agent 
Ovoinhibitor 1.5 49 Inhibits serine 
proteases 
Cystatin 0.05 12.7 Inhibits 
thioproteases 
Ovoglycoprotein 1.0 24.4 Sialoprotein 
Ovoflavoprotein 0.8 32 Binds riboflavin 
Ovomacroglobulin 0.5 760-790 Strongly antigenic 
Avidin  0.05 68.3 Binds biotin 
Other proteins 4.2   
 
 
2.3.1.2 Ovalbumin 
Ovalbumin is often used as a reference protein in biochemistry as a carrier, stabilizer, 
blocking agent, and standard (Abdou et al., 2013). Two peptides, ovokinin and ovikin 
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(2-7) are derivatives of ovalbumin that have been associated with preventing 
hypertension. Ovokinin is obtained via peptic digest of ovalbumin, and ovokinin (2-7) 
is obtained from chymotryptic digest of ovalbumin (Anton et al., 2006). Research has 
also has shown antioxidant, anticancer, and antimicrobial properties (Mine 2008).   
 
2.3.1.3 Ovotransferrin 
Ovotransferrin is an iron-binding protein. It can be used as a nutritional supplement in 
products like protein supplements, iron supplements, and other iron fortified foods 
and beverages (Abdou et al., 2013). While lysozyme is effective at inhibiting Gram-
postitive bacteria, ovotransferrin can inhibit Gram-negative bacteria by depriving the 
bacteria of iron, which is essential to its growth (Anton et al., 2006).  
 
2.3.2 Egg Yolk Bioactive Proteins 
The egg yolk contains bioactive components mostly in the form of proteins (17% of 
yolk) and lipids (34%). The most researched physiological functions of the egg yolk 
are their antibacterial, antiviral, anticancer, antioxidant, anti-inflammatory, and 
immunological properties (Mine, 2008). The lipoproteins, phosvitin, and livetins are 
the main bioactive proteins, as well as precursors to bioactive peptides, in the yolk. 
The hen’s liver synthesizes the egg yolk protein, secretes it into the blood stream, 
transfers it to the ovary, and then finally to the oocyte to accumulate yolk (Mine, 
2008).  Often it is the case that the bioactive peptides within the protein are inactive 
in its native form, and released upon proteolysis during digestion or processing 
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(Samaraweera et al., 2011). It is worth noting that the lipid portion of the egg yolk 
contains many bioactives, although will not be mentioned in detail this review.  
 
2.3.2.1 Lipoproteins 
Although LDL is commonly known for its emulsifying abilities, it also has bioactive 
properties. One study by Shinohara et al. (1993) looked at the effects of lipoproteins 
on the growth and production of IgM in a human-human hybridoma cell. The LDL 
portion was shown to promote the production of the IgM (Abdou et al., 2013). Egg 
yolk has also been used to preserve mammalian spermatozoa against cold shock in 
frozen semen stored for artificial insemination. It has been suggested that the LDL is 
responsible for the resistance against cold shock, as well as improved motility after 
storage. The mechanism proposed for this property could be that the LDL adheres to 
cell membranes during the freeze-thawing, protecting the spermatozoa membranes 
(Anton et al., 2006). While there is not extensive research on this cryoprotective 
property, it could be useful beyond sperm preservation. 
 
The HDL portion of egg yolk is important for antimicrobial activity. Kassaify and 
Mine (2004) studied the effect of non-immunized egg yolk powder on the pathogens 
S. enteritidis, S. typhimurium, and E. coli O157:H7 when included in the hens’ feed. 
At powder concentrations between 5-10%, colonization of all mentioned pathogens 
were either eliminated or reduced in the intestines, as well as elimination or reduction 
in the internal organs.  The results showed inhibited colonization, as well as invasion, 
implying anti-adhesive properties of egg yolk.  A later study by Kassaify et al. in 
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2005 announced that this anti-adhesive effect is associated with the HDL and their 
peptides (Mine and Kovacs-Nolan, 2006).  
 
The lipoproteins in egg yolk are important protein precursors to biologically active 
peptides. When vitellenin, an apoprotein of yolk lipovitellenin (LDL), is digested 
with pronase, it forms glycopeptides A and B. Glycoprotein A has a high content in 
sialic acid, a carbohydrate known for blood protein half-life regulation, toxin 
neutralization, regulation of cellular adhesion, and inhibition of cell cytosis. It is 
proposed that these peptides could be used as carriers of sialic acid, aiding in its 
adsorption and bioavailability (Zambrowicz, et al., 2014).  
 
2.3.2.2 Phosvitin 
Due to its structure, phosvitin has a high ability to chelate metals, particularly 
calcium, magnesium, and iron. The majority of iron present in the yolk is bound to 
phosvitin. Even under thermal stress, phosvitin maintains its high ability to bind iron 
when compared to other phosphoproteins (Samaraweera et al., 2011) Xu et al. (2007) 
found that phosvitin also has a higher ability to bind iron that its phosphopeptide 
derivatives. This metal binding capacity is partly responsible for certain bioactive 
traits, including antibacterial and anti-oxidative, as well as its emulsifying properties. 
Research has shown antibacterial activity against E. coli under thermal stress, as it 
disrupts the cells and DNA of the bacteria. This effect is caused by a combination of 
the metal-chelating abilty and high surface activity (Mine and Kovacs-Nolan, 2006). 
Though the phosphopeptides from phosvitin exhibit higher antioxidant properties, the 
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phosvitin itself also shows to have antioxidant activity. In a phospholipid emulsion 
system with Fe2+, Cu2+, and hemin, the phosvitin successfully inhibited Fe2+ and Cu2+  
mediated oxidation of lipids, though not effective against hemin-mediated 
phospholipids oxidation. This antioxidant activity went down after autoclaving, 
however was maintained at pasteurization temperatures (Samaraweera et al., 2011). 
 
 Phosphopeptides from milk caseins are used in industry for their antioxidant, 
mineral-binding, and anti-microbial effects. Egg yolk phosvitin has not yet received 
as much attention for the production of phosphopeptides. Egg yolk phosvitin is the 
most phosphorylated protein in nature and could be a better source of 
phosphopeptides but could because it contains more phosphates in the molecule than 
casein (Samaraweera et al., 2011). A study by Xu et al. (2007) examined antioxidant 
activity and iron binding capability of tryptic digests of hen egg yolk phosvitin. They 
found that phosvitin, and phosvitin oligophosphopeptides (PPP) both inhibited 
linoleic acid oxidation, however the PPP were significantly more effective, even at a 
lower concentration than the phosvitin. Since PPP’s only contain 35% the amount of 
phosphorous compared to phosvitin, they concluded that the ability of PPP to inhibit 
linoleic acid oxidation is not solely from its metal ion-binding capability. PPPs 
antioxidant effect could also be from the amino acid composition and/or sequence.  
 
2.3.2.3 Immunoglobulin Y 
Immunoglobulin Y technologies have been increasingly gaining attention for all of 
their potential applications, including disease prevention in humans, medical 
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diagnoses, and an alternative to antibiotics in animal feed. There are many advantages 
to using immunoglobulin Y (IgY) from hen’s egg yolk over traditionally used 
mammalian IgG. There are benefits to animal welfare, cost effectiveness, and no 
problematic interactions. Antibiotics are used in the livestock industry for growth and 
disease prevention for over 50 years. However, in recent years, the industry has been 
under pressure to find an alternative because of the growing rate of antibiotic 
resistance in animals and humans. The E.U. banned antibiotics for growth production 
in 2006, and the U.S. FDA started phasing out non-medical antibiotic use in livestock 
at the end of 2013 (Li et al., 2015).  
 
IgY passive immunization therapy could be an effective alternative to antibiotics. In 
passive immunity, the antibodies produced from one individual are transferred to 
another, like in the case of a mother to her newborn via the placenta or a hen to her 
egg. In contrast, active immunization is where the animal has to produce its own 
antibodies, after acquiring a disease or receiving a vaccination. (CDC, 2017) Because 
hens transfer their antibodies to their chick in the yolk, immunizing the hen will 
produce eggs composed of the specific antibodies. This could easily be done orally as 
a feed additive, usually as a freeze- or spray-dried powder (Marcq et al., 2013).  
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Figure 2.6 Production of antigen-specific IgY from laying hens for passive 
immunization via animal feed (Marcq, et al., 2013) 
 
Oral administration of IgY has shown it could be a valuable treatment for numerous 
enteric infections, including rotaviruses, enterotoxigenic E. coli, Salmonella, and H. 
pylori. Studies with oral treatment of pathogen specific IgY have been successful in 
treating rotavirus, E. coli and Salmonella in studies done on animals (Karlsson et al., 
2004).  
 
Antibodies specific to certain pathogens can effectively be orally administered to 
humans to build protective immunity. Unless someone has an allergy to eggs, IgY 
from eggs can be given orally with virtually no risk of side effects because eggs are a 
normal dietary ingredient (Anton et al., 2006). Heliobacter. pylori is a pathogen that 
resides in the gastric and duodenal muscosa that causes gastritis and ulcers and infects 
over half the population worldwide. Antibiotics are usually administered to patients 
with H. pylori, but are sometimes ineffective or have adverse side effects.  When H. 
pylori colonizes in the gastric mucosa, it produces urease enzyme to degrade urea into 
ammonia. H. pylori uses the ammonia to neutralize the microenvironment in gastric 
27 
 
muscosa. Subsequently, urease specific IgY has ben created, and has proved to work 
to suppress the H. pylori colonization. In Japan yogurt fortified with IgY urease made 
from egg yolk was developed to decrease H. pylori. Clinical studies in Japan, Korea, 
and Taiwan all showed significant results in a decrease in the bacteria in volunteers 
who ate the yogurt twice daily for 12 weeks (Anton et al., 2006). 
 
Although specific antibodies have been prepared and collected from the blood serum 
of small mammals such as rabbits, goats, and guinea pigs, there are many advantages 
to using chicken IgY as an alternative. It is a far less invasive procedure to procure 
IgY from eggs than it is to procure IgG from mammals. For eggs, the chicken is 
vaccinated and the eggs collected. The yolk and white are separated, and the IgY is 
extracted from the yolk from a choice of extraction processes. It is a much more 
invasive procedure to extract IgG from mammalian serum because the animals must 
be bled to obtain the antibodies.  Also, the egg yolk only has IgY to begin with, while 
mammalian serum additionally has IgA and IgM that need to be separated out (Mine, 
2008). In addition to animal welfare, egg yolk is a more cost effective source than 
mammals. One hen can produce the same amount of antibodies in a year that would 
take 4.3 rabbits to produce. The cost is also lower to maintain laying hens than 
mammals (Li et al., 2015). Functionally, chicken IgY is advantageous to use in 
humans over mammalian serum IgG because there is no cross reactivity between 
chicken IgY and mammalian IgG. Mammalian IgG activates with Fc and complement 
receptors, which is not a problem with chicken IgY. Not only does this make IgY a 
better choice for immune responsiveness in humans, but also reduces interference 
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problems when used in immunological assays (Karlsson et al., 2004). Another study 
by Nilsson et al. (2012) looked at the stability of IgY stored at room temperature, 
above 4°C. Over a six month period, they found no reduction in antibody activity. 
This means that eggs could potentially stored for at least six months at room 
temperature without decline in antibodies, allowing increased batch sizes in 
production. 
Table 2.7 Egg yolk IgY compared to mammalian IgG 
(Adapted from Mine, 2008) 
 
Egg Yolk IgY Mammalian IgG 
Molecular weight of ~180,000 kDa Molecular weight of ~150,000 
H-chain region contains 4 domains H-chain region contains 4 
domains 
Isoelectric point= ~6.0 Isoelectric point =~7.0 
Thermal denaturation= 73.9°C Thermal denaturation=77.0°C 
Does not activate complement of mammals  
Does not combine with proteins A and G  
(IgG binding proteins) 
 
Does not combine with a rheumatic factor  
Does not combine with Fc receptor of mammalian 
a cell 
 
 
 
2.4 Effects of processes on structure and functionality of yolk fractions 
When egg yolk is fractionated, the plasma and granules behave differently than the 
native yolk. By using the fractions, as opposed to the whole yolk, there is more of an 
opportunity to maximize the functionalities of the yolk, as well as by products that are 
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produced from processes like protein extractions. The microstructure of the egg is 
what gives it much of its functionality, and can be exploited by different treatments. 
Modifications of the pH, ionic conditions, and presence of mineral cations all closely 
effect the structure and function (Causeret et al., 1991).  
 
2.4.1 Salt 
Ionic strength greatly affects the solubility of the granule fraction, but not the plasma. 
At ionic strength below 0.1M NaCl, complete yolk is 25% solubilized. For plasma, it 
is about 80% solubilized, and granules only 10%. The solubility for the yolk and 
granules rose to ~80% with an increase to 0.3M NaCl, while the plasma remained at 
80% solubility. When raised to 0.5 M NaCl, these values remained the same (Anton 
and Gandemer, 1997). The granules reach complete disruption at 1.71M NaCl, 
releasing the HDL and phosvitin from their complexes. The solubility increase with 
addition of NaCl is because phosvitin is a soluble protein at low levels of salt, and 
HDL behaves like soluble proteins (Anton, 2013). The reason for low solubility of 
granules below 0.3M NaCl, is due to the structure; specifically the HDL-phosvitin 
complexes. When NaCl is increased to above 0.3M, the phosphocalcic bridges linking 
HDL and phosvitin are disrupted by monovalent sodium (Anton and Gandemer, 
1997). Emulsions made with yolk, plasma and granules all showed no difference at 
0.5M NaCl, however, in distilled water the granules have a lower emulsifying activity 
than plasma. It is suggested that the granules have a similar emulsifying capability at 
0.3M NaCl that plasma has in its native form (Strixner and Kulozik, 2013).  
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Figure 2.7 Effect of NaCl on protein solubility at pH 7  
(Anton and Gandemer, 1997) 
 
2.4.2 pH 
Previous findings about the pH of the granule fraction has shown a mixed relationship 
with functionality of the product. Causeret (1991) observed that when the original pH, 
in the case of the study 6.3, that both an increase and decrease in pH could disrupt the 
granules. At a pH less than 4.2 or above 6.3, the solubility and viscosity of the 
mixture increased. The acidification or alkalization both break up the phosphocalcic 
bridges that link the HDL and phosvitin. However, when brought back to original pH, 
the solubilization was reversed and returned to the original low solubility.  Research 
by Anton (2013) shows that pH does not have a strong effect on the solubility and 
emulsifying properties of plasma, but a strong effect on granules. His study found that 
granules are insoluble aggregates and were essentially unusable at too low of a pH, 
but become soluble micelles at a pH ~7. 
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Figure 2.8 Effect of pH and NaCl on protein solubility  (Anton, 2013) 
 
2.4.3 Temperature (Freeze/Thaw)  
The effect of temperature on egg yolk products is particularly important because egg 
products are often pasteurized to a temperature between 60-68°C microbial safety. 
Even so, pasteurization temperatures do not completely remove all pathogenic 
organisms, and egg products must be kept at 4°C with a limited shelf life. Studies 
have shown that granules are resistant to heat treatment, while plasma is sensitive. 
This is largely due to the denaturation that occurs in the plasma proteins, y-livetins, a-
livetins, and LDL (Denmat et al., 1999).  The granule proteins’ abilities to resist heat 
was originally thought to be because of the phosphocalcic bridges, but newer research 
suggests otherwise. A study by al Anton et al. (2000) showed that although β 
phosvitin and β HDL were not affected by heating, α-HDL was. Since both forms of 
HDL are linked by the phosphocalcic bridges with phosvitin, this complex is not what 
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protects the proteins from denaturation. Rather, it could be that difference in protein 
composition is responsible for its heat resistance. Yet, the native structure of the 
granules does restrict aggregation of the HDL and phosvitin, avoiding gelation and 
decreased protein solubility. This implies that the granules could be heated to 
pasteurization temperatures without losing emulsifying capabilities (Anton, 2013) A 
study by Denmat et al. (1999) showed the emulsifying stabilization of both granules 
and plasma are mostly unaffected by heat, the emulsifying activity went down for 
plasma above 72°C, while granules remained unaffected.   
 
Freezing is a way to preserve yolk and yolk products in storage over longer periods of 
time. Yolk undergoes gelation during freeze thawing, likely from the LDLs (Anton, 
2013). Under a scanning electron microscope it was shown that an unfrozen sample 
of egg yolk had a close-knit structure with small voids, compared to the frozen-
thawed yolk. The frozen-thawed sample had a much coarser network appearance. 
They also saw a more open network when the samples were diluted, and conversely, 
an even closer knit structure upon concentration. This could mean that the addition or 
removal of water could result in lipoprotein destabilization and aggregation (Hasiak 
et al., 1972).  
 
2.5 Impact on Industry 
The American Egg Board (AEB) reports that today the United States produces 
roughly 75 billion eggs per year, at 10 percent of the world’s supply. Of the supply, 
60 percent are used by consumers, 9 percent used by foodservice industry, and about 
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30 percent used for food manufacturing industry. As specific egg components are 
becoming used more and more for their functional properties in both the food and 
cosmetic industries, there is a growing demand for industrial scale extraction and 
isolation processes that are safe for consumers.  
 
2.5.1 Large Scale Protein Extractions 
The development of antibodies for immunotherapeutic and immunodiagnostic 
therapies is expanding. Because of the many advantages of chicken IgY over 
mammalian IgG, eggs as a source of antibodies is increasingly important. This poses 
the problem of isolating the IgY because of the high concentrations of lipids present 
in the egg yolk (Nilsson et al., 2008). Early publications of methods for IgY 
extraction were not efficient at the industrial scale, and often were not food-safe, as 
they relied on the use of organic solvents. Methods since have become more cost 
efficient and safer, utilizing salt, adjusted pH, temperature, and food gums. 
 
Multiple methods for extracting and isolating IgY based on a simple water dilution 
have been studied and published. Akita and Nakai (1992) compared four different 
purification methods of IgY: water dilution, polyethylene glycol, dextran sulphate, 
and xanthan gum. The study concluded that the water dilution was the most efficient 
method because the procedure was simple, produced high yields of active IgY, and 
can be easily adapted for large scale production. In the water dilution method 
described by Akita and Nakai, they used a 9:1 water to yolk dilution, incubated it at 
4°C for 6 hours, and then centrifuged it. Upon centrifugation, the granules formed a 
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compact sediment on the bottom, and the supernatant could be easily decanted off for 
further purification treatments.  
 
Modifications to the basic water dilution methods have been able to improve 
efficiency of the purification method. Akita and Nakai (1992) used a sixfold water 
dilution with an adjusted pH of 5.0-5.2 incubated at 4°C for 6 hours to obtain a 
recovery of IgY at 93-96%. Another study by Hodek et al. (2012) utilized pH, salt, 
and freeze thawing in their water dilution method. They used a 1:7 water to yolk 
dilution at pH 5.0, and then froze the contents to -20*C and thawed before additional 
adjustments to the water soluble fraction. Following thawing, they adjusted the pH to 
4.0 and added NaCl to a concentration of 8.8% before centrifugation. They obtained a 
purity of 97% IgY recovery.  
 
2.5.2 By Products  
Eggs are becoming an important source of phospholipids and immunoglobulins, and 
their extractions leave large quantities of by-products behind. Many of these by-
products are full of valuable bioactive and functional elements. As the demand for 
these large scale extractions has been recognized over recent years, there has been a 
growing interest to utilize the by-products left behind.  
 
2.5.2.1 Enzymatic Proteolysis  
The by-products of egg extractions are potentially full of proteins and peptides with 
bioactivities. The bioactive peptides are inactive in their precursor sequence, but once 
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released, interact with receptors in the body, regulating functions of systems such as 
nutrient uptake, immune defense, antioxidant, antimicrobial, antiadhesive, and ACE-
inhibitory. A common method to obtain the bioactive peptides is to use enzymatic 
proteolysis with enzymes from animals, plants, or microbes (Eckert et al., 2014).   
 
A study by Eckert et al. (2014) examined the use of an unconventional proteinase 
from Asian pumpkin (Cucurbita ficifolia) to obtain bioactive peptides from the by-
product of a phospholipid extraction from egg yolk. They found that the serine 
protease from C. ficifolia successfully recovered peptides with ACE-inhibitory 
properties. Another study by Zambrowicz et al. (2012) investigated the antioxidant 
and antimicrobial activity of hydrolysates from egg yolk by-product after lecithin 
removal. They prepared hydrolysates from trypsin, chymotrypsin, and pepsin. Higher 
antioxidative effects were found in hydrolysates treated by trypsin and chymotrypsin 
than those of pepsin. They also found that the trypsin treated hydrolysates showed 
weak antimicrobial activity against some Bacillus species. Park et al. (2013) also 
looked at the antioxidative properties of peptides prepared from protein hydrolysate 
of lecithin-free egg yolk with the enzyme Alcalase. They found antioxidative 
properties present, and varied among different molecular weights.  
 
2.5.2.2 Rheological Properties  
The by-products from industrial processes have also been considered for their 
rheological properties in foods. After removal of livetins, the physiochemical 
properties of egg yolk are altered, but have potential to be salvaged as an emulsifier. 
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Emulsions using this by-product are less stable than egg yolk. They have a higher 
viscosity and viscoelastic moduli, likely because of an increase in hydrogen bonds 
and hydrophobic interactions in this fraction (Zambrowicz et al., 2012). Marcet et al. 
(2014) considered egg yolk granules for a low-cholesterol replacer of whole egg yolk 
in gluten-free muffins. They found that the bakery product made with the granules 
was similar to the one made with whole egg yolk. However, they also found that the 
viscoelastic behavior of the batter was altered. The effect on the baked product was a 
harder muffin and a change in color. There are confirmed differences in the 
rheological properties of egg yolk fraction by-products compared to whole egg, and 
more research needs to be done with consumer testing to see if using yolk by-product 
as a replacement for egg is a viable option.  
 
2.6 Summary 
With increasing novel uses for specific egg portions in the food, cosmetic and 
pharmaceutical industries, there is more of a need for large scale commercial 
extractions. The food industry produces substantial amounts of “waste” by-products 
from different egg processing. These by-products are known to be rich in bioactive 
proteins, antibodies, and functional phospholipids (Schmidt et al., 2006). Further, 
Granules are often a by-product from defatted lipid and IgY extractions (Eckert et al., 
2014). With the recognition of IgY as an important source of antibodies, there is a 
significant need to find uses for the granule by-product of industrial scale IgY 
extractions. While previous literature has focused on techniques for such extractions, 
the utilization of the protein by-products has not been widely studied and reported on. 
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By adapting techniques used on whole egg yolk extractions for the granule by-
product portion, there is potential for separation of more proteins. Addition of salt is a 
known way to disrupt the granule fraction. Further, the change of density with 
addition of salt inverts the granules above the water soluble (WS) layer. This 
adaptation could optimize the processing and collection of protein by eliminating 
unnecessary steps and equipment used to siphon the WS layer from the top, and 
instead collect it from the bottom of the tank.  
 
Consequently, this project seeks to find potential uses for protein by-products of 
industrial IgY extractions by further treatment (filtration, salt addition, and pH 
adjustment). Based on previous literature, the following hypotheses were developed: 
1) The egg yolk granule by-product can further fractionate and recover more 
water soluble proteins from lipid fraction by mechanical treatment 
(filtration and centrifugation). 
2) The amount of crude protein salvaged from egg yolk granule by-product 
can be increased/optimized with changes in pH and salt concentration. 
3) Recovered protein and protein hydrolysates can have antibacterial 
properties against Escherichia coli (E. coli)  
The objectives of this study include: 
1) To characterize the recovered protein after the different treatments 
(mechanical, salt, pH) in yolk by-product. 
2) To determine the protein concentration at which antibacterial properties 
are effective against E. coli 
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3) To use salt to attempt to invert the fractionation of the insoluble yellow 
layer on top and water soluble layer on bottom for ease of collection.  
39 
 
 
CHAPTER 3: MATERIALS AND METHODS 
3.1 Yellow Cake Collection and Standardization 
3.1.1 Collection 
A by-product from an experimental pilot plant IgY extraction, which will be called 
yellow cake, was obtained from lipoprotein fraction of a 3 part water soluble protein 
extraction from a project run by Nestle. Pasteurized, non-homogenized, egg yolk 
product used for original Nestle extraction was prepared by La Belle Associates, Inc. 
Sixty pounds of egg yolk were added to stainless steel conical tank. After a 10 fold 
water egg yolk dilution was made, stirred for six hours, and allowed to settle for 12 
hours, a yellow lipoprotein sedimentation formed on the bottom of the tank, showed 
in Figures 3.1 and 3.2 A lobe pump was used to siphon out the water soluble IgY 
fraction from the tank. The sediment was diluted again following the same steps twice 
more. The water soluble fraction was used for further isolation and purification for an 
industry project, leaving behind a yellow lipid/protein sedimentation on the bottom of 
the tank. This waste layer, the yellow cake, was collected in containers by opening 
the valve at the bottom of the tank. After collection, the yellow cake was frozen in 
sanitized plastic tubs and stored at -20°C degrees. Three independent replicates of 
yellow cake samples were obtained from different weeks.   
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Figure 3.1 Phase Separation of egg yolks during IgY extraction. Water soluble 
layer is visible over lipid layers 
 
 
 
Figure 3.2 Yellow cake solids in tank before removal (work of this thesis project) 
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3.1.2 Standardization  
Frozen samples of yellow cake were given forty-eight hours to thaw at 4°C. Once 
thawed, the yellow cake was gently stirred continuously for one minute to ensure a 
homogenous sample.  The CEM LabWave9000 Microwave Moisture/Solid Analyzer 
was then used to measure the percent total solids of the yellow cake under the settings 
for cream. The percent solids readings were taken three times and then averaged. The 
results were used to dilute the yellow cake to a solution of five percent solids in tap 
water. The samples were prepared in seven 10 gallon, stainless steel milk cans at 15 
pounds of solution each.  
 
Figure 3.3 Flow diagram indicating the procedure to generate the samples and 
treatments in this work. 
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3.2 Sock Filtration 
3.2.1 Sample Preparation 
The five percent solids yellow cake solutions were prepared at four different pHs: 4.6 
± 0.05, 4.8 ± 0.05, 5.0 ± 0.05, and 5.2 ± 0.05. Experimental treatmeants are shown in 
Figure 3.3. A 10% Lactic Acid solution was added to the fifteen pounds of yellow 
cake solution to adjust pH. These four solutions at different pHs had no salt added. 
PerpHecT digital LogR Advanced Benchtop pH/mV/ORP/ Temperature Meters Orion 
350 was used for pH measurements.  
 
 
Figure 3.4 Experimental Design for Sock Filtration Experiment 
 
The five percent solids yellow cake solutions were prepared at four different NaCl 
concentrations by weight: 0%, 0.5%, 1%, and 2.5%. NaCl was added to milk cans 
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with 15 lbs of yellow cake solution and mixed vigorously for two minutes before pH 
adjustment.  
 
3.2.2 Filtration 
Tri Clover Mainstream filter, shown in Figure 3.5, was used with a 100 micron mesh 
sock filter to pass through the yellow cake solutions through the first pass. The 
solution was pumped through the filtration system. A hose was used to pass the 
treated yellow cake samples through the pump, which connected to the filter system 
via a plastic hose, and passed through the 100 micron filter and out of stainless steel 
piping. Tap water was run through the filter first for thirty seconds, and then the 
yellow cake solution was pumped through, and filtrate collected into clean milk cans 
for a second pass. A second pass was repeated with the filtrate through a 10 micron 
felt sock filter. Filters were cleaned and changed, and system was emptied and 
cleaned in between each sample can.  
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Figure 3.5 Sock Filtration Set up 
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Figure 3.6 Filter after running samples through 
 
 
Figure 3.7 Filtrate samples collected after passing through filter system 
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3.2.3 Sampling 
After pushing water through the filter, the samples were pushed through and after 30 
seconds the filtrate started to come through yellowish in color. After another 30 
seconds upon color change, samples were collected in milk cans until all of the 
sample was pushed through, shown in Figure 3.6 and 3.7. Additional water was 
pushed through after all of the sample solution was taken up. Thirty seconds after the 
water was added, sample collection stopped and the remainder filtrate was discarded. 
This was to ensure a consistent sampling procedure to optimize a most pure sample 
undiluted with the initial water and final water. Yellow lipid solids left in filter were 
discarded. The collected protein solution was kept for analysis. 
 
3.2.4 Filtrate Storage 
Two complete sample sets of filtrate (protein) for each of the three trials were stored 
in Falcon 50 mL Conical Centrifuge tubes for analysis. Remaining samples were 
stored in 7 oz Whirl-Pak write on bags used for the precipitation portion of the 
project. Upon collection and bagging, they were immediately frozen at -20°C degrees 
until analysis.  
 
3.3 Precipitation 
3.3.1 Sample preparation 
Frozen samples of yellow cake solids were thawed and standardized to a five percent 
solids solution in water with the same procedure as 3.1.2 at a lab scale. 500 mL of 
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solution were prepared in 1000 mL glass beaker.  Yellow cake solution was 
distributed into ten Falcon 50 mL Conical Centrifuge tubes, with 30 mL in each tube. 
Preliminary experimentation showed that a minimum of 2.5% NaCl yellow cake 
solution was needed in order to make the lipid layer start to separate and float 
separation after centrifugation. NaCl concentration of each tube was adjusted to 
3%,4%,5%,6%, and 7%. Appropriate weights of NaCl were measured and added to 
the solutions. They were then dissolved by vigorously shaking the tubes by hand. 
Two tubes were made of each concentration. Figure 3.8 shows a flow of this 
experiment. 
 
 
Figure 3.8 Precipitation Design Flow 
 
3.3.2 Centrifugation 
Eppendorf Centrifuge 5810 R was used to centrifuge the samples in the 50 mL falcon 
tubes samples were prepared in at 4000 RPM for 20 min at 4°C. After centrifugation, 
a gelatinous yellow layer of lipid was on the top with a clear layer on the bottom. The 
clear water soluble layer from each sample was extracted using a 50 mL pipette and 
put into a new 50 mL falcon tube. The lipid layers were discarded.  
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3.3.3 Acidification and incubation 
Hydrochloric acid .5M (HCl) was used to acidify all of the remaining water soluble 
portion of the samples to pH 4±0.05. One sample tube of each salt concentration was 
left to incubate at room temperature for 1.5 hours, while the other sample tube for 
each salt concentration was incubated at 4°C for 1.5 hours. After the incubation 
period, samples turned to a milky white color, and started to have sediment settle at 
the bottom. All sample tubes were centrifuged a second time at 4000 RPM for 20 
minutes at 4°C.  
 
3.3.4 Collection and storage 
After second centrifugation, white pellets formed on the bottom of each falcon tube, 
with a distinct clear layer on the top of all but two tubes. The tubes with 3% NaCl had 
some yellow particles still suspended in the water. The water layer was decanted for 
each tube and discarded. The pellets were each dissolved in 5mL of DI water and 
stored at 4°C for one day until analysis.  
 
3.4 Protein Analysis 
3.4.1 Protein quantification 
3.4.1.1 Preparation 
The frozen treated samples of yellow cake were taken out of the freezer to thaw 
overnight for protein analysis. Samples were balanced and put in Falcon 15mL 
Conical Centrifuge tubes. An Avanti J-E Centrifuge (Beckman Coulter) was used to 
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centrifuge samples at 4,500 RPM for 15 minutes at 4° C with a JS-5.3 rotor. 
Supernatent was analyzed.  
 
3.4.1.2 BCA 
A bicinchoninic acid (BCA) Protein Assay Kit (Pierce Biotechnology, Rockford, IL) 
was used to detect and quantify the total protein. To prepare the protein standard for 
the appropriate working range for the Microplate Procedure (Pierce Biotechnology 
Rockford, IL), a 1 mL ampule containing bovine serum albumin (BSA) at 2mg/mL in 
0.9% saline and 0.05% sodium azide was diluted into mini eppendorf tubes (.5 mL) 
using DI water as the diluent. The samples were prepared in two different dilutions to 
assure the samples would fall into the working range. Preliminary studies showed that 
all samples would have best results undiluted or with a 1:9 dilution. Samples were run 
undiluted, as well as 1:9 dilution. The following formula was used to calculate the 
total volume of working reagent (WR) required: 
 
The WR was prepared by mixing 50 parts of BCA Reagent A from the kit with 1 part 
of BCA Reagent B. Reagent A contained of sodium carbonate, sodium bicarbonate, 
bicinchoninic acid and sodium tartrate in 0.1 M sodium hydroxide. Reagent B 
contained 4% cupric acid. WR was prepared immediately before use. Twenty five µl 
of each sample were pipetted into separate wells in a 96 well microplate (Pierce 
Biotechnology Rockford, IL). 25 µL of each standard were also pipetted into separate 
wells. Each sample and standard were run in duplicate and averaged. 200 µL of the 
WR was added to each well and mixed on a shaker plate for 30 seconds. The plate 
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was covered with parafilm and incubated at 37°C for 30 minutes. Following 
incubation, the plate was cooled to RT. The absorbance was measured at 562 nm on a 
plate reader. A molecular devices SpectraMax M2e device was used to read 
absorbances. 
 
3.4.2 Protein characterization 
3.4.2.1 Preparation 
SDS-PAGE was used to characterize the proteins in different treatments of pH and 
salt concentration in the filtration experiment and for the different concentrations of 
salt and temperature in the precipitation experiment. Samples analyzed with SDS-
PAGE were from the same preparation and sample pool as section 3.4.1.1. The 
samples were then diluted in a 1:1 ratio with Lammeli buffer. To prepare the sample 
buffer, 2x Lammeli buffer (Bio-Rad Laboratories, Hercules, CA) was mixed in a 19:1 
dilution with β-mercaptoethanol (ME) (Fisher Scientific). 1.9 mL of 2x Lammeli 
buffer was mixed with 100 uL of ME. 50 µL of buffer were mixed with 50 µL of 
sample in mini eppendorf tubes. Tubes were boiled for 5 minutes. After cooling to 
room temperature, samples were centrifuged in a minispin plus eppendorf centrifuge 
(Sigma-Aldrich) for 60 seconds at 12,000 RPM. For the precipitation experiment, 
samples from section 3.3.4 were shaken on a vortex for 30 seconds each before gel 
preparation same as above. However, the precipitation samples were additionally 
prepared in a 1:10 dilution with buffer.  
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3.4.2.2 Gel Electrophoresis 
Mini-PROTEAN TGX Precast 4-20%, 10 comb, 50 uL well Gels (Bio-Rad 
Laboratories, Hercules, CA) were assembled into running module cells and chambers 
were filled with 1X Tris-Glycine-SDS buffer(Bio-Rad Laboratories, Hercules, CA). 
10 uL of Precision Plus Protein Dual Color Standards (Bio-Rad Laboratories, 
Hercules, CA) and 10 uL of each prepared sample were loaded into each well. The 
gels were run with a Bio Rad PowerPac Basic power supply at 90 V until the protein 
bands entered the resolving gel. The voltage was then increased to 110 V until the 
bands reached the reference lines and power turned off. The process took 
approximately one hour and forty five minutes.  
 
Gels were stained for 48 hours in Coomassie Brilliant Blue with shaking. Following 
staining, gels were destained with destaining solution(40% methanol, 10% acetic 
acid, 50% deionized water). Gels sat in destain solution with shaking for 20 minutes, 
then the destain solution was changed out for fresh and remained destaining for 24 
hours. After 24 hours, the gels were rinsed with DI water. The gels were imaged on a 
Molecular Imager Gel Doc XR+ with Image Lab 4.1 Software (Bio-Rad laboratories, 
Hercules, CA) with Trans white light.  
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3.5 Antibacterial Function of bioactives 
3.5.1 Bacteria and broth preparation 
3.5.1.1 E. coli 
E. coli strain ATCC 25922 was grown on LB media using the streak plate method 
from pure culture. Plate was incubated overnight at 37°C. The next day the E. coli 
was inoculated in liquid media. 3 mL of sterile Mueller Hinton broth were added to 
sterile test tube. Bacteria sample was scooped from plate into test tube and then 
incubated for 24 hours at 37°C. Prior to MIC procedure, turbidity of E. coli was 
adjusted to 1-2 x 10^8 cfu/mL at OD 600. A blank cuvette of 1mL of MHB broth was 
run at 600 nm in the SpectraMax M2e, followed by a 1:10 dilution of the bacterial 
culture. The results were a concentration of 1.7 x 109 cfu/mL. 
 
Equation 1. To calculate 5 mL of 10^8 cfu/mL of E. coli 
(1.7 x 10^9)/mL (X) = (1 x 10^8)/mL x (5mL)  
X=0.294 mL of E. coli in 4.7 mL of MHB 
 200 uL of adjusted bacterial suspension was added to 19.8 mL of sterile MHB to 
prepare 20 mL of a 1:100 dilution of inoculum.  
 
3.5.1.2 Broth 
Mueller Hinton Broth was prepared by adding DI water to a flask with MHB powder. 
It was stirred with heating until dissolved. It was then autoclaved for 15 minutes, and 
cooled and stored until use.  
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3.5.2 Minimal Inhibitory Concentration (MIC) 
The MIC procedure used was adapted from the method described in Nature Protocols 
by Wiegand et al. (2008). This procedure was mostly used to find the MIC for 
antibiotic drugs, but was adapted for proteins and peptides with bacteriostatic 
properties.  
 
3.5.2.1 Protein standardization and preparation  
BCA was run (Section 3.4.1) on filtration protein samples immediately prior to MIC 
procedure. Results from BCA were used to standardize solution concentrations of 256 
µg/mL of crude protein in MHB.  Protein samples were diluted in MHB for MIC 
plates without TrypZean. Protein samples were diluted in PBS (Bio-Rad Laboratories, 
Hercules, CA) for proteolyzed plates. 1 mL of each sample was prepared.  
 
3.5.2.2 Controls  
Each MIC microtiter plate had 3 individual columns controlling for three different 
variables. The unhydrolyzed plates each had one column with a mixture of E. coli and 
MHB with no protein to ensure adequate bacteria growth from culture. The 
proteolyzed plates had this column with PBS as well, to ensure the growth in the 
presence of PBS. Each plate had one column of the standardized 256 µg/mL protein 
samples with broth and no bacteria to control for contaminated protein. The non 
proteolyzed plates also had a column with just broth to control for contaminated 
broth. The proteolyzed plates had this column with MHB and PBS. 
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3.5.2.3 Dilutions  
For each trial, 50 uL of MHB were pipetted into columns 2-10, and 12 of independent 
sterile 96 microtiter plate. 100 uL of MHB was added into column 11. For each row 
100 uL of standardized 256 µg/mL peptide solution was pipetted into column 1. 
Hydrolyzed plates used the digested samples to be described in the next section. For 
each row, 50 uL from column 1 was withdrawn and pipetted into column 2 with a 
multichannel micropipette. This step was repeated for dilution up until column 9.  
Fresh tips were changed for each withdrawl, and lids were kept close on microtiter 
plates were on whenever not in use to minimize chance of contamination.  
 
 
3.5.2.4 Inoculation  
Each well containing the peptide solution and growth control well were inoculated 
with 50 µL of the bacterial suspension. This resulted in the desired inoculum of 5x 
10^5 cfu/mL. The microtiter plates were then incubated at 37°C for 20 hours. After 
the 20 hours, the plates were observed and minimum inhibitory concentrations 
determined by growth/no growth across the plates. Figure 3.9 visualizes the plate. 
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Figure 3.9 Example of MIC plate. Protein across rows is in µg/mL 
3.6 Enzyme Digest 
3.6.1 TrypZean preparation 
Sample of TrypZean from Cal Poly with a specific activity of 4538 USP units/mg was 
used to digest protein samples from the filtration experiment. To prepare a 20mg/mL 
concentration of TrypZean, 10 mg of lyophilized dessicated TrypZean powder was 
mixed into 500 uL of 1mM HCl. To make the 1mM HCl, 100 uL of 1M HCl were 
added into 99.9 mL of DI water.  
 
3.6.2 Proteolysis 
The MIC assay was run both with and without proteolysis on the samples. Each trials 
1-3 had their own plate for an MIC assay without proteolysis performed, and each 
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had a separate plate for proteolysis without an endpoint. Trial 2 had 2 additional 
plates to test proteolysis with an endpoint.  
 
2.56 uL of prepared TrypZean were added to each standardized protein sample from 
trials 1-3 and incubated for 2 hours at 37°C.  For trial 2 samples this portion was run 
an additional 2 times to test different endpoints. After incubation period, one set of 
trial 2 samples were boiled for 5 minutes. One set from trial 2 samples were heated to 
50°C for 5 minutes. All other samples had no endpoint. These samples were then 
pipetted into wells on microtiter plate for serial dilution and inoculated according to 
the same procedure in 3.5.2.3 and 3.5.2.4. 
 
 
3.7 Statistical Analysis 
JMP pro 13 was used for analysis in the sock filtration experiment. Response for 
protein amount was analyzed using a two factor ANOVA. Results were considered 
significant with a p-value < 0.05. Statistical analysis and graphs for the raw data can 
be found in the appendix as noted.  
 
 
 
57 
 
CHAPTER 4: RESULTS AND DISCUSSION 
4.1 Sock Filtration 
4.1.1 Protein Content 
SDS-PAGE was used to profile the proteins contained in the yellow cake after 
filtration. Samples were subjected to and analyzed under seven different conditions, 
considering two variables: NaCl content and pH.  After diluting samples, gels were 
run accordingly, taking care that the tracking dye did not travel farther than the 
bottom of the gels. Gels were stained using Coomassie Brilliant Blue to view the 
bands.   
 
Figures 4.1, 4.2, and 4.3 illustrate the protein content in the three replicated trials for 
the sock filtration. For all all three figures: Lane one represents the protein standard. 
Lane 2 represents 0% NaCl, pH of 5.2. Lane 3 represents 0.5% NaCl, pH of 5.2. Lane 
4 represents 1% NaCl, pH of 5.2. Lane 5 represents 2.5% NaCl, pH 5.2. Lane 6 
represents 0% NaCl, pH of 4.6. Lane 7 represents 0% NaCl, pH of 4.8. Lane 8 
represents 0% NaCl, pH of 5.0.  
 
All three trials showed the same migration patterns. Most bands appeared in the 37-75 
kDa range, though some very light. In all seven treatments, two most distinct bands 
appeared at 75 kDa and ~45kDa. There were also lighter, but distinct bands among all 
samples at 37 and ~65 kDa, although barely detectable in trial 3 image. In the image 
for trial 2, lanes 4 and 8 have extra bands appearing at 125 and ~119 kDa. In all 
images, lane 5 had much darker, distinct bands, as well as more bands. These bands 
58 
 
appeared at 250 kDa, ~30(absent in trial 1) ~8, ~13, and a darker diffuse band 
between 100-130 kDa (faint in trial 1). In general, bands were most pronounced in 
trial 3, and faintest in trial 1.  
 
Bands were compared to known weights of expected proteins in previous literature. 
Protein identities were estimated by comparison with mobilities of standards. The 
prominent band at 75 kDa appeared across all trials and treatments, as expected, 
because it corresponds with one of the major apoproteins apparent in all fractions of 
egg yolk in previous literature (Itoh et al., 1986).  The other prominent band that 
appeared on trials and treatments at ~45kDa confirmed the presence of β-phosvitin 
(Abe et al., 1982; Itoh et al., 1986, Ko et al., 2011) The 37 kDa band is estimated to 
be α-phosvitin or riboflavin binding protein (RFB) (Abe et al., 1982; Awade, 1995). 
The bands at 65 kDa and 125 kDa, and 250 kDa could be attributed to one of the 
main apoproteins of LDL (Itoh et al., 1986).  
 
Lane 5 had 2.5% NaCl and a pH of 5.2. It had 5 unique and distinct bands that the 
other samples at 5.2 pH with less salt concentrations did not have. These bands were 
at ~225, ~13, 7~, ~30, and ~100. Additionally, these bands were unique among the 
other pH samples with 0% NaCl concentrations. Bands at ~7 and ~13 were likely 
apolipovitellenins. (Awade, 1995; Zambrowicz et al., 2014; Anton and Gandemer, 
1997) The band at ~30 corresponds to an apoprotein of HDL (Mine, 2008). It is likely 
that the higher salt concentration solubilized more proteins out of the yellow cake 
solution by disruption of the granule structure. At full disruption of granules, the 
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presence of more unique proteins is likely due to the broken HDL-phosvitin 
complexes allowing those proteins to be released and solubilized in this environment. 
In salt concentrations under 2.5%, there are still different proteins and peptides that 
are bound in the phosvitin-HDL complexes.  
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Figure 4.1. Trial 1 filtrate samples run on SDS-PAGE (4-20% gel) visualized 
with Coomassie staining. Lane 1. Protein Standard; Lane 2. 0% NaCl, pH of 5.2; 
Lane 3. 0.5% NaCl, pH of 5.2; Lane 4. 1% NaCl, pH of 5.2; Lane 5. 2.5% NaCl, 
pH 5.2; Lane 6. 0% NaCl, pH of 4.6; Lane 7. 0% NaCl, pH of 4.8; Lane 8. 0% 
NaCl, pH of 5.0. The molecular sizes of the marker are given in kDa.  
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Figure 4.2. Trial 2 filtrate samples run on SDS-PAGE (4-20% gel) visualized 
with Coomassie staining. Lane 1. Protein Standard; Lane 2. 0% NaCl, pH of 5.2; 
Lane 3. 0.5% NaCl, pH of 5.2; Lane 4. 1% NaCl, pH of 5.2; Lane 5. 2.5% NaCl, 
pH 5.2; Lane 6. 0% NaCl, pH of 4.6; Lane 7. 0% NaCl, pH of 4.8; Lane 8. 0% 
NaCl, pH of 5.0. The molecular sizes of the marker are given in kDa.  
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Figure 4.3. Trial 3 filtrate samples run on SDS-PAGE (4-20% gel) visualized 
with Coomassie staining. Lane 1. Protein Standard; Lane 2. 0% NaCl, pH of 5.2; 
Lane 3. 0.5% NaCl, pH of 5.2; Lane 4. 1% NaCl, pH of 5.2; Lane 5. 2.5% NaCl, 
pH 5.2; Lane 6. 0% NaCl, pH of 4.6; Lane 7. 0% NaCl, pH of 4.8; Lane 8. 0% 
NaCl, pH of 5.0. The molecular sizes of the marker are given in kDa.  
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4.1.2 Protein Quantification  
Total amounts of crude protein in the yellow cake samples after filtration and 
preparation (with centrifugation) were analyzed using a Thermo Scientific Pierce 
BCA Protein Assay kit (Rockford, IL). The BCA method was chosen over the Biuret, 
Lowry, and Bradford methods because of its higher sensitivity and lower variability. 
Sample preparations from trials 1-3 were run both with a 1:9 dilution and undiluted. 
The undiluted data all fell within the working range and was subsequently used for 
analysis, as well as for standardization for the MIC procedure. 
 
After centrifugation, a small milky yellow sediment formed on the bottom of the 
falcon tubes, with the exception of the sample with 2.5% NaCl. This tube formed a 
yellow pellicle on the top of the tube. The tubes with 1% NaCl had small floating 
light yellow particles suspended in solution. The supernatant was then prepared and 
analyzed with BCA.  
 
 
Figure 4.4 Sediment formed on bottom of centrifuged samples. From right to 
left: pH 5.2: 0% NaCl, 0.5% NaCl, 1% NaCl, 2.5% NaCl. 0% NaCl: pH 4.6, pH 
4.8. Pellicle formed on trial with 2.5% NaCl 
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Figure 4.5 From right to left: pH 5.2: 0% NaCl, 0.5% NaCl, 1% NaCl, 2.5% 
NaCl. 0% NaCl: pH 4.6 Floating particles in tube with 1% salt  
 
A protein standard of bovine serum albumin (BSA) was used as reference to 
determine unknown protein amounts. The microplate procedure was used to run the 
samples and standards. After running the samples in the spectrometer at 562 nm, the 
unknown sample protein amounts were determined based on the standard curve.  
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Table 4.1 Averaged protein concentration from BCA after treatments 
Trial number Salt Conc % pH Avg Protein Conc in ug/ml 
1 0 5.2 692 
1 0.5 5.2 776 
1 1 5.2 532 
1 2.50% 5.2 985 
1 0 4.6 730 
1 0 4.8 691 
1 0 5 1265 
2 0 5.2 669 
2 0.5 5.2 763 
2 1 5.2 388 
2 2.50% 5.2 3051 
2 0 4.6 306 
2 0 4.8 537 
2 0 5 221 
3 0 5.2 283 
3 0.5 5.2 518 
3 1 5.2 401 
3 2.50% 5.2 1468 
3 0 4.6 429 
3 0 4.8 281 
3 0 5 284 
 
The results for the different levels of NaCl effect on protein concentration did show 
that NaCl concentration had a statistical significance, as salt concentration had a p-
value <0.05. Overall, there was a noticeable trend of higher protein concentrations 
with the addition of salt. However, data showed there was a small decrease with 1% 
salt, which could be due to a few reasons. It is likely the suspended particles present 
in the 1% salt samples interfered with the BCA analysis, giving an inaccurate reading.  
If there was no interference, there could be a salting in effect on the protein. The 
increase at 2.5% is likely due to the disruption of the granules, solubilizing phosvitin 
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and HDL (Huopalahti et al., 2007). At this concentration, the phosphocalcic bridges 
would break with sodium replacement of calcium. The free phosvitin would 
solubilize because of the salt concentration. At a concentration at 2.5% NaCl, the 
most protein is extracted, as well as more types of proteins, as shown from the 
previous section in the gels. Figure 4.6 visualizes the effect of NaCl on protein 
concentration. 
 
 
Figure 4.6 Effect of NaCl on protein concentration 
 
 
The results in the pH range of 4.6-5.2 did not prove to be statistically significant. 
There is no evidence that pH adjustments within this range have an effect on the 
protein concentration. Figure 4.7 visualizes the effect of pH on protein concentration. 
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Figure 4.7 Effect of pH on protein concentration 
 
 
4.2 Precipitation 
4.2.1 Observations of addition of NaCl  
Lab scale samples of yellow cake were diluted in water to make a 5% solids solution. 
After adjusting the solution to samples of 5 different salt concentrations and the first 
round of centrifugation, a gelatinous pellicle formed on the top of the solution. At 3% 
NaCl content, there were visible puffy light yellow clumps and strands floating just 
below the pellicle. At 4% and 5% NaCl, there were less clumps hanging attached to 
the bottom of the pellicle layer. By 6% NaCl, there appeared to be complete 
separation, as well as 7%. This is shown in figures 4.8-4.12. 
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Figure 4.8 3% NaCl Solution             Figure 4.9 4% NaCl Solution  
 
 
 
 
Figure 4.10 5% NaCl Solution 
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  Figure 4.11 6% NaCl Solution                Figure 4.12 7% NaCl Solution 
 
The adjustment of density with addition of salt allowed the insoluble yellow layer to 
invert and form a pellicle on top. At 3% NaCl, the pellicle was less compact with 
strands attached to it, as well as a more turbid water-soluble portion. By the 
concentration of 6% NaCl, the pellicle on top was compacted with no floating 
particles beneath it. 
 
After addition of HCl and centrifugation, firm white pellets precipitated on the 
bottom of the falcon tubes. In an industry scale extraction, this simple inversion, 
followed by precipitation could make the process more efficient. When collecting the 
water soluble protein fraction, it could be easily emptied from the bottom of the tank, 
then run through a centrifuge or separator, and then the protein pellet collected. This 
eliminates a more complicated process of siphoning and pumping the water soluble 
fraction out when it is the floating layer on top.  
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4.2.2 Protein Content 
SDS-PAGE was used to profile the proteins contained in the reconstituted pellet from 
the precipitation experiment. Samples were subjected to and analyzed under ten 
different conditions, considering two variables: NaCl content and temperature.  After 
diluting samples, gels were run accordingly, taking care that the tracking dye did not 
travel farther than the bottom of the gels. Gels were stained using Coomassie Brilliant 
Blue to view the bands.   
 
Figure 4.13 illustrates the protein content in the supernatant from the precipitation 
experiment. These samples are the result of the procedure illustrated in diagram 3.7. 
Lane 1 represents the protein standard. Lane 2 represents 3% NaCl incubated at room 
temperature (RT). Lane 3 represents 4% NaCl incubated at RT. Lane 4 represents 5% 
NaCl incubated at RT. Lane 5 represents 6% NaCl incubated at RT. Lane 6 represents 
7% NaCl incubated at RT. Lane 7 represents 4% NaCl incubated at 4°C. Lane 8 
represents 5% NaCl incubated at 4°C. Lane 9 represents 6% NaCl incubated at 4°C. 
Lane 10 represents 7% NaCl incubated at 4°C.  
 
The same migration pattern appeared across all sample treatments for the 
precipitation treatments. Bands ranged from 10 kDa to 250 kDa. The largest, 
prominent band appeared at ~125 kDa as diffuse band. Smaller bands appeared under 
it in the 100-125 kDa range. There were more prominent bands at ~74, ~45, ~35,and 
~29 kDa. The addition of salt at this range did not affect the different proteins 
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solubilized. It is likely that the granules are already completed disrupted at a 
concentration at 2.5%.  
 
The band at 125 kDa is likely apoprotein of LDL (Awade 1995; Zambrowicz et al., 
2014). At 100-125, 74, 28 and 45 kDa, the bands are likely polypeptides of HDL 
(Awade 1995; Zambrowicz et al., 2014; Strixner and Kulozik, 2013). It is possible the 
~35 marker is β-livetin, if there was some leftover from the plasma fraction, but not 
likely.  
 
Figure 4.13 Precipitation samples run on SDS-PAGE (4-20% gel) visualized with 
Coomassie staining. Lane 1. Protein Standard; Lane 2. 3% NaCl, room 
temperature (RT); Lane 3. 4% NaCl, RT; Lane 4. 5% NaCl, RT; Lane 5. 6% 
NaCl, RT; Lane 6. 7% NaCl, RT; Lane 7. 4% NaCl, 4°C; Lane 8. 5% NaCl, 4°C; 
Lane 9. 6% NaCl, 4°C; Lane 10. 7% NaCl, 4°C. The molecular sizes of the 
marker are given in kDa.  
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4.3 MIC 
Three plates, one from trial 1, 2, and 3, were assayed without proteolysis. Crude 
protein was standardized to 256 µg/mL in MHB and diluted according to procedure. 
After 20 hours of incubation at 37°C, growth/no growth was observed. The test 
results for the MIC procedure are based on a growth/no growth response to find the 
lowest concentration of proteins to inhibit the growth of bacteria. Although the results 
did not conclusively show a minimum inhibitory concentration, the patterns are worth 
examining for potential insight about the possible antibacterial properties of the 
protein extract.  
 
4.3.1 No Proteolysis 
For Trial 1, there was no growth in any of the wells in the control columns 11 and 12. 
For column 10 with just E. coli and broth, there was growth in all cells in the column. 
This confirms the MHB and the protein were not contaminated, and that the E. coli 
was present in sufficient amount. There were no other wells with zero growth, 
however all wells in columns 1 and 2 with higher protein concentrations showed less 
turbidity, implying less growth.  
 
For Trial 2, there was no growth in all wells in column 12 or in column 11 wells B,C, 
and D. This shows there may have been some contamination of the protein samples 
for this trial. There was were no other wells with zero growth. Like Trial 1, columns 1 
and 2 were less turbid, as well as wells 5C and 5D.  
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For Trial 3, there was slight growth in column 11, and no growth in column 12. There 
may have also been some slight contamination in the protein from this trial. All other 
wells in all columns had similar turbidity throughout.  
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Figure 4.14 Trial 1 MIC with no proteolysis 
Row A: 0.0% NaCl, pH=5.2 
Row B: 0.5% NaCl, pH=5.2 
Row C: 1.0% NaCl, pH=5.2 
Row D: 2.5% NaCl, pH=5.2 
Row E: 0.0% NaCl, pH=4.6 
Row F: 0.0% NaCl, pH=4.8 
Row G: 0.0% NaCl, pH=5.0 
Row H is empty 
Protein Concentrations in MHB inoculated with E. coli: 
Column 1: 256 µg/mL 
Column 2: 128 µg/mL 
Column 3: 64 µg/mL 
Column 4: 32 µg/mL 
Column 5: 16 µg/mL 
Column 6: 8 µg/mL 
Column 7: 4 µg/mL 
Column 8: 2 µg/mL 
Column 9: 1 µg/mL 
Controls: 
Column 10: E. coli and MHB 
Column 11: 256 µg/mL protein solution in MHB 
Column 12: MHB 
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Figure 4.15 Trial 2 MIC with no proteolysis 
Row A: 0.0% NaCl, pH=5.2 
Row B: 0.5% NaCl, pH=5.2 
Row C: 1.0% NaCl, pH=5.2 
Row D: 2.5% NaCl, pH=5.2 
Row E: 0.0% NaCl, pH=4.6 
Row F: 0.0% NaCl, pH=4.8 
Row G: 0.0% NaCl, pH=5.0 
Row H is empty 
Protein Concentrations in MHB inoculated with E. coli: 
Column 1: 256 µg/mL 
Column 2: 128 µg/mL 
Column 3: 64 µg/mL 
Column 4: 32 µg/mL 
Column 5: 16 µg/mL 
Column 6: 8 µg/mL 
Column 7: 4 µg/mL 
Column 8: 2 µg/mL 
Column 9: 1 µg/mL 
Controls: 
Column 10: E. coli and MHB 
Column 11: 256 µg/mL protein solution in MHB 
Column 12: MHB 
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Figure 4.16 Trial 3 MIC with no proteolysis 
Row A: 0.0% NaCl, pH=5.2 
Row B: 0.5% NaCl, pH=5.2 
Row C: 1.0% NaCl, pH=5.2 
Row D: 2.5% NaCl, pH=5.2 
Row E: 0.0% NaCl, pH=4.6 
Row F: 0.0% NaCl, pH=4.8 
Row G: 0.0% NaCl, pH=5.0 
Row H is empty 
Protein Concentrations in MHB inoculated with E. coli: 
Column 1: 256 µg/mL 
Column 2: 128 µg/mL 
Column 3: 64 µg/mL 
Column 4: 32 µg/mL 
Column 5: 16 µg/mL 
Column 6: 8 µg/mL 
Column 7: 4 µg/mL 
Column 8: 2 µg/mL 
Column 9: 1 µg/mL 
Controls: 
Column 10: E. coli and MHB 
Column 11: 256 µg/mL protein solution in MHB 
Column 12: MHB 
77 
 
 
4.3.2 Proteolysis no endpoint 
Three plates, one from trial 1, 2, and 3, were assayed with proteolysis without an 
endpoint. Crude protein was standardized to 256 µg/mL in a solution of PBS and 
enzyme solution and then diluted according to procedure. 2.56 µL of prepared 
TrypZean were added to each well of sample and incubated for 2 hours at 37°C. After 
20 hours of incubation at 37°C, growth/no growth was observed. Figure 4.17-4.19 
illustrates the growth patterns.  
 
For Trial 1, there was no growth in column 12, and there was a very small button 
appeared down wells in column 11. Wells in column 1 had less turbidity than all other 
columns. All other columns showed similar turbidity throughout.  
 
For Trial 2, there was no growth in column 12, with a small button in column 11. 
Wells in column 1 had less turbidity than all other columns. There also appeared to be 
a gradient of turbidity across the rows.  Well D5 also showed hardly any turbidity.  
 
For Trial 3, there was no growth in column 12. Column 11 had no growth in wells D 
and E, with small button in the rest of the column. The turbidity increased across 
rows.  The gradient that appeared in plates from trial 2 and 3 show a possibility of 
some bacteriostatic property. Although there is no conclusive evidence in this assay, 
this gradient appeared most prominently in the plates that had proteolysis without an 
endpoint. There is a possible release of peptides after addition of TrypZean that may 
inhibit some E. coli growth. The samples with proteolysis with an endpoint did not 
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show this pattern, implying that the enzymatic reaction needed more time for 
digestion. Although this is only speculative because MIC is a growth/no growth test, 
there are implications for potential bacteriostatic activity in the peptides.  
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Figure 4.17 Trial 1 MIC with proteolysis with no endpoint 
Row A: 0.0% NaCl, pH=5.2 
Row B: 0.5% NaCl, pH=5.2 
Row C: 1.0% NaCl, pH=5.2 
Row D: 2.5% NaCl, pH=5.2 
Row E: 0.0% NaCl, pH=4.6 
Row F: 0.0% NaCl, pH=4.8 
Row G: 0.0% NaCl, pH=5.0 
Row H is empty 
Protein Concentrations in MHB inoculated with E. coli: 
Column 1: 256 µg/mL 
Column 2: 128 µg/mL 
Column 3: 64 µg/mL 
Column 4: 32 µg/mL 
Column 5: 16 µg/mL 
Column 6: 8 µg/mL 
Column 7: 4 µg/mL 
Column 8: 2 µg/mL 
Column 9: 1 µg/mL 
Controls: 
Column 10: E. coli and MHB + PBS 
Column 11: 256 µg/mL protein solution in MHB/TrypZean 
Column 12: MHB and PBS 
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Figure 4.18 Trial 2 MIC with proteolysis with no endpoint 
Row A: 0.0% NaCl, pH=5.2 
Row B: 0.5% NaCl, pH=5.2 
Row C: 1.0% NaCl, pH=5.2 
Row D: 2.5% NaCl, pH=5.2 
Row E: 0.0% NaCl, pH=4.6 
Row F: 0.0% NaCl, pH=4.8 
Row G: 0.0% NaCl, pH=5.0 
Row H is empty 
Protein Concentrations in MHB inoculated with E. coli: 
Column 1: 256 µg/mL 
Column 2: 128 µg/mL 
Column 3: 64 µg/mL 
Column 4: 32 µg/mL 
Column 5: 16 µg/mL 
Column 6: 8 µg/mL 
Column 7: 4 µg/mL 
Column 8: 2 µg/mL 
Column 9: 1 µg/mL 
Controls: 
Column 10: E. coli and MHB + PBS 
Column 11: 256 µg/mL protein solution in MHB/TrypZean 
Column 12: MHB and PBS 
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Figure 4.19 Trial 3 MIC with proteolysis with no endpoint 
Row A: 0.0% NaCl, pH=5.2 
Row B: 0.5% NaCl, pH=5.2 
Row C: 1.0% NaCl, pH=5.2 
Row D: 2.5% NaCl, pH=5.2 
Row E: 0.0% NaCl, pH=4.6 
Row F: 0.0% NaCl, pH=4.8 
Row G: 0.0% NaCl, pH=5.0 
Row H is empty 
Protein Concentrations in MHB inoculated with E. coli: 
Column 1: 256 µg/mL 
Column 2: 128 µg/mL 
Column 3: 64 µg/mL 
Column 4: 32 µg/mL 
Column 5: 16 µg/mL 
Column 6: 8 µg/mL 
Column 7: 4 µg/mL 
Column 8: 2 µg/mL 
Column 9: 1 µg/mL 
Controls: 
Column 10: E. coli and MHB + PBS 
Column 11: 256 µg/mL protein solution in MHB/TrypZean 
Column 12: MHB and PBS 
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4.3.3 Proteolysis with endpoints 
Two additional plates run with samples from trial 2 were assayed with proteolysis 
with different endpoints. Crude protein was standardized to 256 µg/mL in a solution 
of PBS and enzyme solution and then diluted according to procedure. 2.56 µL of 
prepared TrypZean were added to each well of sample and incubated for 2 hours at 
37°C. One set was boiled for 5 min, and one set was incubated at 50°C for 5 minutes. 
After an additional 20 hours of incubation at 37°C, growth/no growth was observed. 
Figures 4.20 and 4.21 illustrate the growth patterns.  
 
The plate with 5 minutes of boiling showed no growth in columns 11(except for 11D) 
or 12. Wells D5 and C3 showed only slight turbidity. Otherwise, there was similar 
growth throughout. 
 
The plate heated to 50°C for 5 minutes showed no growth in column 12, and no 
growth in column 11 wells C and D. Otherwise column 11 showed a slight turbidity. 
F8 had no growth. Columns 1 and 2 were less turbid than other columns.   
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 Figure 4.20 Trial 2 MIC with proteolysis with boiling as endpoint 
Row A: 0.0% NaCl, pH=5.2 
Row B: 0.5% NaCl, pH=5.2 
Row C: 1.0% NaCl, pH=5.2 
Row D: 2.5% NaCl, pH=5.2 
Row E: 0.0% NaCl, pH=4.6 
Row F: 0.0% NaCl, pH=4.8 
Row G: 0.0% NaCl, pH=5.0 
Row H is empty 
Protein Concentrations in MHB inoculated with E. coli: 
Column 1: 256 µg/mL 
Column 2: 128 µg/mL 
Column 3: 64 µg/mL 
Column 4: 32 µg/mL 
Column 5: 16 µg/mL 
Column 6: 8 µg/mL 
Column 7: 4 µg/mL 
Column 8: 2 µg/mL 
Column 9: 1 µg/mL 
Controls: 
Column 10: E. coli and MHB + PBS 
Column 11: 256 µg/mL protein solution in MHB/TrypZean 
Column 12: MHB and PBS 
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Figure 4.21 Trial 2 MIC with proteolysis heated to 50°C as endpoint 
Row A: 0.0% NaCl, pH=5.2 
Row B: 0.5% NaCl, pH=5.2 
Row C: 1.0% NaCl, pH=5.2 
Row D: 2.5% NaCl, pH=5.2 
Row E: 0.0% NaCl, pH=4.6 
Row F: 0.0% NaCl, pH=4.8 
Row G: 0.0% NaCl, pH=5.0 
Row H is empty 
Protein Concentrations in MHB inoculated with E. coli: 
Column 1: 256 µg/mL 
Column 2: 128 µg/mL 
Column 3: 64 µg/mL 
Column 4: 32 µg/mL 
Column 5: 16 µg/mL 
Column 6: 8 µg/mL 
Column 7: 4 µg/mL 
Column 8: 2 µg/mL 
Column 9: 1 µg/mL 
Controls: 
Column 10: E. coli and MHB + PBS 
Column 11: 256 µg/mL protein solution in MHB/TrypZean 
Column 12: MHB and PBS 
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CHAPTER 5: CONCLUSIONS AND LIMITATIONS 
The main purpose of this thesis was to find a use for an industrial egg yolk by-product 
from IgY extraction that has previously been treated as waste. This objective included 
exploring techniques for separating proteins from lipids from the by-product, as well 
as quantifying and characterizing recovered proteins. Furthermore, it was 
hypothesized that the protein extract would show anti-microbial properties against E. 
coli.  
 
This study showed that the by product of the IgY extraction is rich in proteins that 
have potential uses. The results proved that addition of NaCl to the yellow cake 
significantly affected the amount of protein recovered. The greatest amount of protein 
recovered was demonstrated at the highest NaCl level tested, 2.5%, suggesting the 
disassociation of the HDL-phosvitin complexes.  The increased amount of salt also 
increased the variety of proteins recovered. At a level of 2.5% NaCl, additional 
unique bands were revealed on the SDS-PAGE gels.  
 
Moreover, as salt addition increased, the water-soluble portion inverted to the bottom 
layer, forming a lipid pellicle on top. With additional pH adjustment and 
centrifugation, a protein pellet formed on the bottom. This is important for an 
industrial scale separation because it will make collection of the protein fraction from 
the bottom of a tank a much easier process. At a concentration of 5% NaCl, the two 
fractions inverted completely. At pH of 4, salt concentration between 3-7% did not 
have an effect on the variety of proteins extracted.  
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There was no evidence that pH has an effect on the amount of protein recovered in 
the range that was tested in this project. It also did not change the variety of proteins 
that were recovered.  
 
There was no conclusive evidence on the anti-bacterial properties of the crude protein 
extract against E. coli. Although there was no quantifiable evidence from the MIC 
assay, the results showed an interesting trend. Some of the plates showed increased 
turbidity across the plates at lower concentrations of the protein extract. This suggests 
that the crude protein extract may have some bacteriostatic abilities. Some of the 
individual proteins and peptides in the extract may harbor these properties. 
 
Due to the nature of projects utilizing by-products, it needs to be considered that there 
are variations in results caused by inconsistencies of the processes upstream. The 
project was confined to three trial replicates because of limited time and resources, 
but more trial replicates would help minimize deviations in the data.  
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CHAPTER 6: DIRECTIONS FOR FUTURE RESEARCH 
This project provides an opening for further research on how to best utilize by-
products from commercial scale IgY extractions. The separation methods laid out are 
a practical solution for the food and cosmetic industries for further separation of 
water soluble fractions because they successfully utilize common equipment and food 
grade materials. It is therefore pragmatic to continue to explore optimization of by-
products of similar nature. Some ideas for future research include: 
• Purification of the peptides in the crude protein extract by means of highly 
accurate techniques, such as HPLC. 
• Expand anti-bacterial study by testing effectiveness of crude protein extract, 
as well as isolated peptides, against a variety of different bacterial organisms, 
including gram-positive and gram-negative. 
• Broaden study to include effect of different types of salt on protein recovery 
• Test for different functionalities of proteins, including antioxidative properties 
Additionally, there are many opportunities for research containing the lipids present 
in the by-product. This would include characterizing and isolating the lipids to use for 
their bioactive and rheologic potential.  
 
 
 
 
88 
 
REFERENCES 
Abdou, A.M., M. Kim, and K. Sato. 2013. Functional Proteins and Peptides of Hen’s 
Egg Origin. Bioactive Food Peptides in Health and Disease. 115–136. 
doi:10.5772/54030.  
Abe, Y., T. Itoh, and S. Adachi. 1982. Fractionation and Characterization of Hen's 
Egg Yolk Phosvitin. Journal of Food Science. 47:1903–1907. 
doi:10.1111/j.1365-2621.1982.tb12910.x.  
Akita, E.M., and S. Nakai. 1992. Immunoglobulins from Egg Yolk: Isolation and 
Purification. Journal of Food Science. 57:629–634. doi:10.1111/j.1365-
2621.1992.tb08058.x.  
Akita, E., and S. Nakai. 1993. Comparison of four purification methods for the 
production of immunoglobulins from eggs laid by hens immunized with an 
enterotoxigenic E. coli strain. Journal of Immunological Methods. 160:207–
214. doi:10.1016/0022-1759(93)90179-b.  
American Egg Board. Industry Overview - American Egg Board.  
Anton, M., and G. Gandemer. 1997. Composition, Solubility and Emulsifying 
Properties of Granules and Plasma of Egg Yolk. Journal of Food Science. 
62:484–487. doi:10.1111/j.1365-2621.1997.tb04411.x.  
Anton, M., M.L. Denmat, and G. Gandemer. 2000. Thermostability of Hen Egg Yolk 
Granules: Contribution of Native Structure of Granules. Journal of Food 
Science. 65:581–584. doi:10.1111/j.1365-2621.2000.tb16052.x.  
Anton, M., F. Nau, and Y. Nys. 2006. Bioactive egg components and their potential 
uses. World's Poultry Science Journal. 62:429–438. 
doi:10.1079/wps2005105.  
89 
 
Anton, M. 2013. Egg yolk: structures, functionalities and processes. Journal of the 
Science of Food and Agriculture. 93:2871–2880. doi:10.1002/jsfa.6247.  
Awade, A.C. 1996. On hen egg fractionation: applications of liquid chromatography 
to the isolation and the purification of hen egg white and egg yolk proteins. 
Zeitschrift f�r Lebensmittel-Untersuchung und -Forschung. 202:1–14. 
doi:10.1007/bf01229676.  
Barrenetxe, J., P. Aranguren, A. Grijalba, J. Martínez-Peñuela, F. Marzo, and E. 
Urdaneta. 2006. Effect of dietary quercetin and sphingomyelin on intestinal 
nutrient absorption and animal growth. British Journal of Nutrition. 95:455–
461. doi:10.1079/bjn20051651.  
Brady, D., S. Gaines, L. Fenelon, J. Mcpartlin, and C. O'farrelly. 2002. A 
Lipoprotein-derived Antimicrobial Factor from Hen-egg Yolk is Active 
Against Streptococcus Species. Journal of Food Science. 67:3096–3103. 
doi:10.1111/j.1365-2621.2002.tb08865.x.  
Causeret, D., E. Matringe, and D. Lorient. 1991. Ionic Strength and pH Effects on 
Composition and Microstructure of Yolk Granules. Journal of Food Science. 
56:1532–1536. doi:10.1111/j.1365-2621.1991.tb08634.x.  
Coutinho, H.D.M., K.M. Lobo, D.A.C. Bezerra, and I. Lobo. 2008. Peptides and 
proteins with antimicrobial activity. Indian Journal of Pharmacology. 
doi:10.4103/0253-7613.40481.  
Denmat, M., M. Anton, and G. Gandemer. 1999. Protein Denaturation and 
Emulsifying Properties of Plasma and Granules of Egg Yolk as Related to 
Heat Treatment. Journal of Food Science. 64:194–197. doi:10.1111/j.1365-
90 
 
2621.1999.tb15863.x.  
Eckert, E., A. Zambrowicz, M. Pokora, B. Setner, A. Dąbrowska, M. Szołtysik, Z. 
Szewczuk, A. Polanowski, T. Trziszka, and J. Chrzanowska. 2014. Egg-yolk 
protein by-product as a source of ACE-inhibitory peptides obtained with 
using unconventional proteinase from Asian pumpkin (Cucurbita ficifolia). 
Journal of Proteomics. 110:107–116. doi:10.1016/j.jprot.2014.08.003.  
Hasiak, R.J., D.V. Vadehra, R.C. Baker, and L. Hood. 1972. Effect Of Certain 
Physical And Chemical Treatments On The Microstructure Of Egg Yolk. 
Journal of Food Science. 37:913–917. doi:10.1111/j.1365-
2621.1972.tb03702.x.  
Hodek, P., P. Trefil, J. Simunek, J. Hudecek, and M. Stiborova. 2013. Optimized 
protocol of chicken antibody (IgY) purification providing electrophoretically 
homogeneous preparations. Int. J. Electrochem. Sci. 8:113–124.  
Immunity Types. 2017. Centers for Disease Control and Prevention.  
Itoh, T., M. Kubo, and S. Adachi. 1986. Isolation and Characterization of Major 
Apoproteins from Hen's Egg Yolk Granule. Journal of Food Science. 
51:1115–1117. doi:10.1111/j.1365-2621.1986.tb13061.x.  
Jolivet, P., C. Boulard, V. Beaumal, T. Chardot, and M. Anton. 2006. Protein 
Components of Low-Density Lipoproteins Purified from Hen Egg Yolk. 
Journal of Agricultural and Food Chemistry. 54:4424–4429. 
doi:10.1021/jf0531398.  
Karlsson, M., H. Kollberg, and A. Larsson. 2004. Chicken IgY: utilizing the 
evolutionary advantage. World's Poultry Science Journal. 60:341–348. 
91 
 
doi:10.1079/wps200422.  
Ko, K.Y., K.C. Nam, C. Jo, E.J. Lee, and D.U. Ahn. 2012. Erratum to "A simple and 
efficient method for preparing partially purified phosvitin from egg yolk 
using ethanol and salts" (Poult. Sci. 90(5):1096-1104). Poultry Science. 
91:1496–1496. doi:10.3382/ps.2012-91-6-1496.  
Küllenberg, D., L.A. Taylor, M. Schneider, and U. Massing. 2012. Health effects of 
dietary phospholipids. Lipids in Health and Disease. 11. doi:10.1186/1476-
511x-11-3.  
Li, X., L. Wang, Y. Zhen, S. Li, and Y. Xu. 2015. Chicken egg yolk antibodies (IgY) 
as non-antibiotic production enhancers for use in swine production: a review. 
Journal of Animal Science and Biotechnology. 6:40. doi:10.1186/s40104-
015-0038-8.  
Mann, K., and M. Mann. 2008. The chicken egg yolk plasma and granule proteomes. 
Proteomics. 8:178–191. doi:10.1002/pmic.200700790.  
Marcet, I., B. Paredes, and M. Díaz. 2015. Egg yolk granules as low-cholesterol 
replacer of whole egg yolk in the preparation of gluten-free muffins. LWT - 
Food Science and Technology. 62:613–619. doi:10.1016/j.lwt.2014.08.031.  
Marcq, C., A. Thewis, D. Portelle, and Y. Beckers. 2013. Refinement of the 
production of antigen-specific hen egg yolk antibodies (IgY) intended for 
passive dietary immunization in animals. Biotechnologie, Agronomie, Société 
Et Environnement. 17(3):483–493.  
Milinsk, M., A. Murakami, S. Gomes, M. Matsushita, and N. de Souza. 2003. Fatty 
acid profile of egg yolk lipids from hens fed diets rich in n-3 fatty acids. 
92 
 
Food Chemistry. 83:287–292. doi:10.1016/s0308-8146(03)00094-3.  
Mine, Y., and J. Kovacs-Nolan. 2006. New insights in biologically active proteins 
and peptides derived from hen egg. World's Poultry Science Journal. 62:87–
96. doi:10.1079/wps200586.  
Mine, Y., C. Oberle, and Z. Kassaify. 2003. Eggshell Matrix Proteins as Defense 
Mechanism of Avian Eggs. Journal of Agricultural and Food Chemistry. 
51:249–253. doi:10.1021/jf020597x.  
Mine, Y., F. Ma, and S. Lauriau. 2004. Antimicrobial Peptides Released by 
Enzymatic Hydrolysis of Hen Egg White Lysozyme. Journal of Agricultural 
and Food Chemistry. 52:1088–1094. doi:10.1021/jf0345752.  
Mine, Y. 2008. Egg bioscience and biotechnology. Wiley-Interscience, Hoboken, NJ.  
Nilsson, E., J. Stålberg, and A. Larsson. 2012. IgY stability in eggs stored at room 
temperature or at  4°C. British Poultry Science. 53:42–46. 
doi:10.1080/00071668.2011.646951.  
Nilsson, E., Hanrieder Jörg, J. Bergquist, and A. Larsson. 2008. Proteomic 
Characterization of IgY Preparations Purified with a Water Dilution Method. 
Journal of Agricultural and Food Chemistry. 56:11638–11642. 
doi:10.1021/jf802626t.  
Park, P.-J., W.-K. Jung, K.-S. Nam, F. Shahidi, and S.-K. Kim. 2001. Purification and 
characterization of antioxidative peptides from protein hydrolysate of 
lecithin-free egg yolk. Journal of the American Oil Chemists' Society. 
78:651–656. doi:10.1007/s11746-001-0321-0.  
Position of the American Dietetic Association: Functional Foods. 2004. Journal of 
93 
 
the American Dietetic Association. 104:814–826. 
doi:10.1016/j.jada.2004.03.015.  
Purdue University. Purdue Food Animal Education Network.  
Samaraweera, H., W.-G. Zhang, E.J. Lee, and D.U. Ahn. 2011. Egg Yolk Phosvitin 
and Functional Phosphopeptides-Review. Journal of Food Science. 76:R143–
R150. doi:10.1111/j.1750-3841.2011.02291.x.  
Schmidt, L.D., G. Blank, D. Boros, and B.A. Slominski. 2007. The nutritive value of 
egg by-products and their potential bactericidal activity:in vitro andin vivo 
studies. Journal of the Science of Food and Agriculture. 87:378–387. 
doi:10.1002/jsfa.2685.  
Sirvente, H., V. Beaumal, C. Gaillard, L. Bialek, D. Hamm, and M. Anton. 2007. 
Structuring and Functionalization of Dispersions Containing Egg Yolk, 
Plasma and Granules Induced by Mechanical Treatments. Journal of 
Agricultural and Food Chemistry. 55:9537–9544. doi:10.1021/jf0719398.  
Slotte, P.J., and B. Ramstedt. 2007. The functional role of sphingomyelin in cell 
membranes. European Journal of Lipid Science and Technology. 109:977–
981. doi:10.1002/ejlt.200700024.  
Song, W.O., and J.M. Kerver. 2013. Nutritional Contribution of Eggs to American 
Diets. Journal of the American College of Nutrition. 19:556S–562S. 
doi:10.1080/07315724.2000.10718980.  
Strixner, T., and U. Kulozik. 2013. Continuous centrifugal fractionation of egg yolk 
granules and plasma constituents influenced by process conditions and 
product characteristics. Journal of Food Engineering. 117:89–98. 
94 
 
doi:10.1016/j.jfoodeng.2013.02.009.  
United States Department of Agriculture. 2000. Egg Grading Manual. Agricultural 
Marketing Service.  
Walther, B., and R. Sieber. 2011. Bioactive proteins and peptides in foods. Int J 
Vitam Nutr Res. 8(2-3):181–192. doi:10.1024/0300-9831/a000054.  
Wiegand, I., K. Hilpert, and R.E.W. Hancock. 2008. Agar and broth dilution methods 
to determine the minimal inhibitory concentration (MIC) of antimicrobial 
substances. Nature Protocols. 3:163–175. doi:10.1038/nprot.2007.521.  
Xu, X., S. Katayama, and Y. Mine. 2007. Antioxidant activity of tryptic digests of 
hen egg yolk phosvitin. Journal of the Science of Food and Agriculture. 
87:2604–2608. doi:10.1002/jsfa.3015.  
Zabłocka, A., A. Sosnowska, A. Urbaniak, M. Janusz, and A. Polanowski. 2014. 
Peptides accompanying chicken egg yolk IgY – alternative methods of 
isolation and immunoregulatory activity. Food &amp; Function. 5:724–733. 
doi:10.1039/c3fo60391a.  
Zambrowicz, A., M. Pokora, E. Eckert, M. Szoltysik, A. Dabrowska, J. Chrzanowska, 
and T. Trziszka. 2012. Antioxidant and antimicrobial activity of lecithin free 
egg yolk protein preparation hydrolysates obtained with digestive enzymes. 
Functional Foods in Health and Disease. 2(12):487–500.  
Zambrowicz, A., A. Dąbrowska, Ł. Bobak, and M. Szołtysik. 2014. Egg yolk proteins 
and peptides with biological activity. Postępy Higieny i Medycyny 
Doświadczalnej. 68:1524–1529. doi:10.5604/17322693.1133600.  
Zambrowicz, A., M. Pokora, B. Setner, A. Dąbrowska, M. Szołtysik, K. Babij, Z. 
95 
 
Szewczuk, T. Trziszka, G. Lubec, and J. Chrzanowska. 2014. Multifunctional 
peptides derived from an egg yolk protein hydrolysate: isolation and 
characterization. Amino Acids. 47:369–380. doi:10.1007/s00726-014-1869-x.  
 
 
 
96 
 
APPENDICES 
Appendix A: BCA output 
1. Standard Curve 
 
97 
 
2. BCA output 
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Appendix B: BCA raw data table 
Trial number Salt Conc % pH Avg Protein Conc in ug/ml 
1 0 5.2 692 
1 0.5 5.2 776 
1 1 5.2 532 
1 2.50% 5.2 985 
1 0 4.6 730 
1 0 4.8 691 
1 0 5 1265 
2 0 5.2 669 
2 0.5 5.2 763 
2 1 5.2 388 
2 2.50% 5.2 3051 
2 0 4.6 306 
2 0 4.8 537 
2 0 5 221 
3 0 5.2 283 
3 0.5 5.2 518 
3 1 5.2 401 
3 2.50% 5.2 1468 
3 0 4.6 429 
3 0 4.8 281 
3 0 5 284 
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Appendix C: JMP output for NaCl study 
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Appendix D: JMP output for pH study 
 
